Transport Of Red And White Blood Cells In Whole Blood Microflows For Microfluidics-Based, In-Vitro Diagnostics Applications by McPeak, Daniel
  
 
 
 
TRANSPORT OF RED AND WHITE BLOOD CELLS IN WHOLE BLOOD 
MICROFLOWS FOR MICROFLUIDICS-BASED, IN-VITRO DIAGNOSTICS 
APPLICATIONS 
 
 
 
 
 
A DISSERTATION 
SUBMITTED TO THE FACULTY OF 
UNIVERSITY OF MINNESOTA 
BY 
 
 
 
 
DANIEL R. MCPEAK 
 
 
 
 
 
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS 
FOR THE DEGREE OF 
DOCTOR OF PHILOSOPHY 
 
 
 
 
DR. EPHRAIM SPARROW, ADVISER 
 
 
 
 
 
December, 2015  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© DANIEL R. MCPEAK,  2016 
  1 
Acknowledgements 
 
I would like to thank my advisor for pushing me to work beyond my personal strengths 
and for his valued wisdom in scientific and personal endeavors. Thanks for everything, 
Eph. 
 
I would like to thank all of the employees of Ativa Medical; the opportunity to work with 
you all is a true blessing.   
 
Special thanks go to Eric Peltola, Taha Najmee, and Karman Lee who have been 
incredible friends and collaborators throughout this project. 
 
Finally, love and thanks to my wonderful family.   
  2 
Dedication 
 
This thesis is dedicated to my family. 
  3 
Abstract 
The research set forth in this thesis was motivated by the desire to create a microfluidic 
device for measuring cell concentrations in whole blood.  Such a technology would 
enable the creation of important point-of-care diagnostic tests such as the Complete 
Blood Count.  The path of investigation documented in this thesis was not carried out in a 
predetermined manner. But rather, the collected thoughts and experiments were spurred 
on by obstacles encountered in the pursuit of the desired technology. While the 
realization of a cell-enumerating device is of key interest, it was found—and is 
shown—that much of the challenge in creating such a device lies in addressing 
innate properties of the blood sample itself.  As a consequence, investigation of these 
properties and their importance with regard to micro-scale cell transport is the primary 
technical focus of the research.  Herein, it is shown that cell transport in creeping whole 
blood micro-flows is dominated by interphase flow brought about by phase-density 
imbalances and the elevated Darcy permeability which is associated with erythrocyte 
aggregation in low-shear flows.  Additionally, non-uniform distribution of cells and the 
non-Newtonian properties of whole blood are hypothesized to affect the transport of 
white blood cells in situations where the rate of bulk flow changes appreciably.  Study of 
these effects by way of experimentation and the development of mathematical 
descriptions of cell transport ultimately led to the creation of a device which circumvents 
deleterious consequences of whole blood behavior and achieves accurate quantitation of 
red and white blood cell concentrations. 
  4 
Table of Contents 
List of Tables ................................................................................................................................... 7 
List of Figures .................................................................................................................................. 8 
Chapter 1: Introduction .................................................................................................................... 1 
1.1 Motivation ........................................................................................................................ 1 
1.2 Point-of-Care Diagnostics Technology ............................................................................ 4 
1.3 Microfluidics .................................................................................................................... 6 
1.4 Research Overview .......................................................................................................... 7 
Chapter 2: Technical Overview of Experimental Apparatus and Microdevice Composition ........ 12 
2.1 Experimental Apparatus ................................................................................................. 12 
2.1.1 Fluid Pumping System ........................................................................................... 13 
2.1.2 Optical Detection ................................................................................................... 17 
2.2 Microdevice Composition and Functionality ................................................................. 18 
2.2.1 Cell Dispensing ...................................................................................................... 19 
2.2.2 Cell Processing ....................................................................................................... 19 
2.2.3 Cell Focusing ......................................................................................................... 20 
2.3 Measurement Methodology ........................................................................................... 21 
Chapter 3: Cell Transport in Vertically-Oriented Whole Blood Microchannel Flows .................. 24 
3.1 Microdevice ................................................................................................................... 24 
3.2 Measurement Routine .................................................................................................... 29 
3.2.1 Additional Fluidic Technique for RBC Measurement ........................................... 30 
3.3 Experimental Procedure ................................................................................................. 31 
3.4 Results ............................................................................................................................ 32 
3.4.1 RBC Concentration Measurements ........................................................................ 32 
3.4.2 WBC Measurements .............................................................................................. 33 
Chapter 4: Cell Transport in Sedimenting Whole Blood ............................................................... 35 
4.1 A Link between Microdevice-Measurement Bias and Whole Blood Composition ....... 35 
4.2 A Working Hypothesis for Microdevice-Measurement Bias ......................................... 37 
4.2.1 Erythrocyte Sedimentation ..................................................................................... 38 
4.3 The Effect of Erythrocyte Sedimentation upon the Rate of Cell Dispensing ................ 40 
  5 
4.3.1 Microdevice Bias as a Function of ESR ................................................................ 42 
4.3.2 Inferring ESR Values from Device-Measurement Bias ......................................... 44 
4.4 WBC Transport in Sedimenting Whole Blood .............................................................. 46 
4.4.1 Description of WBC Flotation ............................................................................... 46 
4.4.2 Comparison of WBC-Measurement Bias with Flotation Model ............................ 50 
Chapter 5: Pertinent Phenomena for Cell Transport in Whole Blood Microflows ........................ 53 
5.1 Effects of Device Loading ............................................................................................. 53 
5.2 Sedimentation in Shearing Whole Blood ....................................................................... 55 
Chapter 6: A Gravity-Bias-Free Transport Domain ...................................................................... 58 
6.1 Cell-Dispensing Domain ................................................................................................ 58 
6.1.1 Principles of Operation .......................................................................................... 59 
6.1.2 Circumventing Gravitational Dispensing Bias....................................................... 61 
6.2 Sustaining Cell Concentrations ...................................................................................... 63 
6.2.1 Problem Formalization ........................................................................................... 63 
6.2.2 Initial Cell Distribution .......................................................................................... 64 
6.2.3 Bulk Cell Transport ................................................................................................ 68 
6.3 Experimental Testing of the Revised Dispensing Domain ............................................ 70 
6.3.1 Microdevice ........................................................................................................... 71 
6.3.2 Measurement Routine ............................................................................................ 75 
6.3.3 Experimental Procedure ......................................................................................... 76 
6.4 Results ............................................................................................................................ 76 
6.4.1 RBC Concentration Measurements ........................................................................ 76 
6.4.2 WBC Concentration Measurements ....................................................................... 77 
6.5 Conclusions .................................................................................................................... 78 
Chapter 7: Directionality of Outlet Transport ................................................................................ 80 
7.1 Outlet Flow Recirculation as Transport Bias ................................................................. 82 
7.2 Density-Driven Outlet Flow Recirculation .................................................................... 84 
7.3 Numerical Simulation of Outlet-adjacent Transport ...................................................... 86 
7.3.1 Mixture Model ....................................................................................................... 87 
7.3.2 Relative Velocity ................................................................................................... 89 
  6 
7.3.3 Simulation Strategy ................................................................................................ 90 
7.4 Baseline Domain Simulation ......................................................................................... 91 
7.4.1 Parameters .............................................................................................................. 92 
7.4.2 Results .................................................................................................................... 92 
7.5 Revised Domain Simulation .......................................................................................... 94 
7.5.1 Parameters .............................................................................................................. 95 
7.5.2 Results .................................................................................................................... 95 
7.6 Experimental Testing of Revised Outlet-adjoining Channel ......................................... 96 
7.6.1 Microdevice ........................................................................................................... 96 
7.6.2 Measurement Routine ............................................................................................ 98 
7.6.3 Experimental Procedure ......................................................................................... 98 
7.7 Results ............................................................................................................................ 99 
7.7.1 RBC Concentration Measurements ........................................................................ 99 
7.7.2 WBC Concentration Measurements ..................................................................... 100 
7.8 Conclusions .................................................................................................................. 101 
Chapter 8: Summary of Results and Conclusions ........................................................................ 103 
8.1 Characterization of Transport in Whole Blood Microflows ........................................ 106 
8.2 Advancement of Point-of-Care, Cell-counting Technology ........................................ 108 
References .................................................................................................................................... 110 
Appendix A: Derivation of Kinematic Description of Cell Transport in a Straight Channel 
Segment of Uniform Cross Section ............................................................................................. 114 
Appendix B: Measurement Routine Tables ........................................................................... 116 
 
 
 
 
  7 
List of Tables 
 
Table 1.  Summary of PID performance at key volumetric flow rates ............................. 16 
Table 2.  Test matrix for the comparison of microdevice and reference instrument 
measurements .................................................................................................................... 32 
Table 3 Baseline domain simulation: material and boundary parameters ........................ 92 
Table 4 Revised domain simulation:  material and boundary parameters ........................ 95 
 
  
  8 
List of Figures 
 
Figure 1-1. From [9]:  Diagram of POCT technology categories ....................................... 5 
Figure 2-1. Schematic overview of device interaction with pumping and optical-detection 
systems .............................................................................................................................. 12 
Figure 2-2.  Diagram of PID-controlled pump ................................................................. 14 
Figure 2-3.  Color-coded classification of White Blood Cell subpopulations: Neutrophil 
(Blue), Lymphocytes (Red), Monocytes (Green), and Eosinophils (Yellow) .................. 17 
Figure 2-4.  Architecture of a microdevice for quantitation of cell concentration in whole 
blood ................................................................................................................................. 19 
Figure 3-1.  Annotated illustration of the microdevice design utilized in the initial 
comparison study .............................................................................................................. 25 
Figure 3-2.  Isometric view of fluid-fluid junction between the cell dispensing and cell 
processing channels within the comparison study device ................................................. 26 
Figure 3-3.  Schematic of the cell focusing feature used in each of the experimental 
devices............................................................................................................................... 27 
Figure 3-4.  Scatterplot illustrating the correlation between microdevice and reference 
instrument measurements of RBC concentration ............................................................. 33 
Figure 3-5.  Scatterplot illustrating the correlation between microdevice and reference 
instrument measurements of WBC concentration ............................................................ 34 
Figure 4-1.  RBC and WBC biases for the comparison study data ................................... 36 
  9 
Figure 4-2.  From [19]:  Cell-plasma interface location as a function of time for various 
hematocrit (HCT) values (from left to right: HCT = 26, 28, 34, 45) ................................ 39 
Figure 4-3.  From [21]; Plot of ESR values for sickle-cell (diamond) and healthy (circle) 
samples .............................................................................................................................. 41 
Figure 4-4.  Plot of ESR values inferred from the comparison study bias (red-filled 
circles) with the bounding box from Figure 4-3 ............................................................... 45 
Figure 4-5.  Plot of calculated and measured WBC-measurement bias (from comparison 
study)................................................................................................................................. 51 
Figure 5-1.  From [29]: Plot of experimental data demonstrating the shear dependence of 
ESR ................................................................................................................................... 57 
Figure 6-1  Detailed view of blood-holding volume, outlet, and transition control volume
........................................................................................................................................... 59 
Figure 6-2  Time-lapse diagram of phases within sedimenting whole blood ................... 60 
Figure 6-3  From [22]:  Left panel: Photograph (multiple exposure) of the distal opening 
of a 69- μm tube with fluorescent leukocytes passing the focal plane of the objective.  
Right panel: Division of the tube cross section into six concentric rings of 5.8- μm width. 
The black dots represent the position of WBCs passing the focal place of the microscope.
........................................................................................................................................... 67 
Figure 6-4  Transport diagram for the central region of the blood-holding volume ......... 69 
Figure 6-5  Annotated layout of the optimized microfluidic device ................................. 71 
Figure 6-6  Illustration of the initial portion of the optimized cell-processing circuit ..... 74 
  10 
Figure 6-7  Scatterplot illustrating the correlation between microdevice and reference 
instrument measurements for RBC concentration ............................................................ 77 
Figure 6-8  Scatterplot illustrating the correlation between microdevice and reference 
measurements of WBC concentration .............................................................................. 78 
Figure 6-9  RBC and WBC biases for Concentration Measurements using the Optimized 
Microdevice ...................................................................................................................... 79 
Figure 7-1 Model velocity profiles for reversed (a) and forward (b) bulk transport ........ 82 
Figure 7-2  Illustration of phase separation in outlet-adjoining channel .......................... 84 
Figure 7-3  Chart of ESR-HCT relationship used within the numerical simulation ......... 89 
Figure 7-4 Diagram of the baseline simulation domain .................................................... 91 
Figure 7-5 Plot of cell-volume fraction within the outlet region of the baseline simulation 
domain............................................................................................................................... 92 
Figure 7-6 Diagram of the revised simulation domain ..................................................... 94 
Figure 7-7 Plot of cell-volume fraction within the outlet region of the revised simulation 
domain............................................................................................................................... 95 
Figure 7-8  Annotated layout of the optimized microdevice with revised outlet-adjoining 
channel .............................................................................................................................. 97 
Figure 7-9  Detail view of whole blood transitioning from the blood-holding volume to 
the cell-processing circuit ................................................................................................. 98 
Figure 7-10  Scatterplot illustrating the correlation between microdevice and reference 
instrument measurements for RBC concentration ............................................................ 99 
  11 
Figure 7-11  Scatterplot illustrating the correlation between microdevice and reference 
measurements of WBC concentration ............................................................................ 100 
Figure 7-12  RBC and WBC biases for Concentration Measurements using the Optimized 
Microdevice .................................................................................................................... 101 
 
  
  1 
Chapter 1: Introduction 
 
The present research is concerned with the characterization of whole blood dynamics 
which are pertinent to microfluidic devices such as those found within point-of-care 
(POC) in-vitro diagnostics applications.  Specifically, emphasis is placed upon 
experimental analysis of cell transport in sub-millimeter-scale blood flows.  There are 
two benefits to be derived from this research: first, said analyses expand the fundamental 
understanding of whole blood behavior; this is especially relevant from the viewpoint of 
microfluidic point-of-care devices.  Secondly, the experimental results inform the 
refinement of the particular microfluidic technology which had inspired this research: a 
microdevice for quantifying cell concentrations in whole blood. Because this technology 
enables the development of POC cell-counting assays such as a Complete Blood Count, 
the technical advancements of this research should enhance the scope of diagnostic tests 
available for use at the point-of-care and in turn contribute to the efficacy and 
accessibility of medical diagnostic services, worldwide.  
 
1.1 Motivation 
The motivation behind this research is rooted in the global need for improved access to 
high-quality, medical diagnostic services.  Though diagnostic testing accounts for a 
relatively small financial fraction of modern healthcare systems, diagnostics influence 
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between (60-70%) of clinical decisions [1].  According to the World Health Organization 
(WHO), accessibility to diagnostic testing is especially lacking in developing countries 
with high disease burdens.  Additionally, The WHO states that three of the primary 
reasons for poor accessibility in low-access regions include: excessive financial burden to 
patients, lack of trained personnel to operate equipment, and long distances separating 
patients from the nearest laboratory [2].  Presently, the medical community is addressing 
these issues with the development of point-of-care diagnostic technologies which are 
economical, easy-to-use, and distributable such that the technologies can be utilized in 
small, dispersed locations like general practitioners’ offices and health clinics [3].  As a 
result of this distribution of medical diagnostic services, informed diagnosis should be 
provided to more patients and with greater efficiency than is possible within existing 
healthcare systems [4].    
 
In established healthcare systems within which diagnostics accessibility is not of 
significant concern, point-of-care testing is targeted more for its impact on workflow 
efficiency.  For example, a 2004 study comparing point-of-care and central-laboratory 
glucose measurements (both methods being performed within a single hospital) 
demonstrated that the financial and labor burdens were approximately halved through the 
of POC testing [5].  In this case, much of the benefit of the POC test related to steps 
which were eliminated from the workflow: sample transport, laboratory receiving, and 
manual result reporting.   
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Workflow efficiency is also the driving force behind the adoption of POC testing by 
general practitioners and health clinics. However, the desired efficiency in these settings 
pertains more to the minimization of the time between first patient contact and an 
informed diagnosis.  With tests available at the point-of-care, practitioners can utilize 
established diagnostic procedures as part of their normal office-visit workflow. 
Subsequently, patients receive informed diagnosis and are prescribed treatment with a 
single visit to their provider.  These benefits are forfeit when a patient’s condition 
requires testing which is unavailable at the point of care.  Under such circumstances, the 
provider must rely on the traditional sources of diagnostic testing wherein the patient is 
referred to a hospital laboratory or a specimen is acquired and sent to a centralized testing 
facility. In either of these scenarios, diagnosis and treatment are delayed and both the 
patient and provider are burdened with follow-up from their initial contact.   
 
One manner of advancement of the point-of-care movement, then, can be thought of as 
reduction of the likelihood that healthcare providers find themselves without the desired 
testing equipment.  Toward that end, the aim of the technology explored within this 
research is to provide POC practitioners with tests requiring quantification of blood cell 
concentrations, such as the Complete Blood Count.  Presently, there is a need for a 
Complete Blood Count technology which satisfies the economics and ease-of-use 
necessitated by the point-of-care model.  The Complete Blood Count (CBC), which 
provides an overview of a patient’s blood composition, serves a key role in the medical 
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diagnostic process as supported by Medicare’s list of the 100 most-frequently-utilized 
procedures for 2007 [6] wherein the CBC is shown to be the most common blood test 
utilized within the Medicare system.  Without the CBC available at the point-of-care, 
there is a critical element missing from the de-centralization of medical diagnostics.  As 
such, research contributing to the development of point-of-care CBC technologies might 
advance POC testing as a whole. 
 
1.2 Point-of-Care Diagnostics Technology 
Point-of-care testing (POCT) is a rapidly-developing area of medical technology which 
aims to equip general practitioners and health clinics with health analytics that were 
traditionally only readily-accessible to hospital staff [7].  In 2010, the National Institute 
of Health released a memo regarding the past, present and future status of the point-of-
care movement.  In this report, the NIH stated that “Empowering clinicians to make 
decisions at the “point-of-care” has the potential to significantly impact health care 
delivery and to address the challenges of health disparities” [8].  With respect to the 
progression of point-of-care testing, the NIH recognizes “the development of 
miniaturized devices” as a critical endeavor.  ‘Devices’ here refers to any in a spectrum 
of technologies, each of which has a set of characteristics which define its role in the 
diagnostic process. In Figure 1-1, POC technologies are segmented into six categories 
ranging from retail-grade dipstick tests (labeled ‘Disposable’) to sophisticated wearable 
and benchtop instruments.   
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Figure 1-1. From [9]:  Diagram of POCT technology categories 
From the viewpoint of a retail consumer, the disposable category of diagnostic devices is 
most familiar; a segment which includes pregnancy tests and glucose strips, the latter of 
which allows diabetics to monitor and subsequently control their blood sugar level.  As a 
general rule, affirmed by loose standards set forth by regulating entities, the ‘disposable’ 
technologies are measurably less accurate than laboratory-grade equivalents.  For 
instance, glucose strips are only required by the International Standards Organization 
(ISO) to provide readings that are within ±15% of a laboratory reference value [10].  This 
standard is substantially less stringent than claimed accuracy of a common handheld 
instrument, the Abbott iStat, which produces glucose measurements which are within 
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±5% of reference values [11].  Still, the standard established for glucose strips ensures 
that they are sufficiently accurate to serve their claimed purpose: to inform a diabetic if 
their blood glucose level is low--requiring sugar intake, high--necessitating a dose of 
insulin.   
 
A device’s ability to support its claimed purpose is the primary concern of the POC 
practitioner and is a key differentiator between POC tests within the disposable category 
and those without. The intended use of laboratory-grade POC technologies, to guide 
diagnosis and treatment, necessitates a high level of accuracy.  The challenge of POC 
technologies, then, is to bridge the performance gap between lab-grade and disposable 
technologies such that the ease-of-use of disposable technologies can be achieved without 
sacrificing diagnostic integrity.  In this research, focus is placed on one form of lab-grade 
POC technology--microfluidic devices--which performs sample processing in low-cost, 
one-time-use fluidic circuits which should enable the ease-of-use of Disposable 
technologies while achieving measurement accuracy equivalent to clinical laboratory 
instruments. 
1.3 Microfluidics 
Microfluidics refers to technologies which utilize precisely-controlled, micro-scale fluid 
flows.  Microfluidic circuits are leveraged in a variety of applications such as fuel cells, 
inkjet printers, and labs-on-a-chip.  Lab-on-a-chip (LOC) technologies are intended to 
perform clinical laboratory procedures in an automated fashion through the utilization of 
  7 
micro-scale fluidic circuits which replace the inner workings of larger, traditional lab 
equipment.   
 
In 2011, a critical review of point-of-care diagnostic research recognized that “A variety 
of theoretical models and academic proof-of-concept studies have demonstrated 
tantalizing advantages of lab-on-a-chip systems…” [12].  However, the authors go on to 
note “surprisingly few LOC-based diagnostic tests have been successfully introduced into 
the market.”  Furthermore, this publication specifies the key challenges which include 
“new methods for sample collection, world-to-chip interfaces, sample pre-treatment, 
improvement of long-term stability of reagents and working with complex sample 
specimens (such as whole blood, stool, swabs, sputum, tears, and saliva).”  The present 
research shall address one facet of the problem of manipulating “complex samples” by 
characterizing the physics of cell transport in whole blood micro flows. 
1.4 Research Overview 
This research consists of a series of experiments aimed at the characterization of red and 
white blood cell transport in whole blood flows which are contained within a LOC 
microdevice. In each experiment, the bulk volumetric flow rate of blood is controlled by 
an off-device pumping system.  Control of the bulk volumetric flow rate allows 
comparison of experimentally-measured transport rates with the desired descriptor of cell 
transport within the flow, given in Equation (1-1).  Equation (1-1) states that the rate at 
which a given cell type is transported within a whole blood flow should be described as 
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the product of the bulk whole blood flow rate and the concentration of the cell type 
within the blood sample.  A derived form of Equation (1-1) is often used to describe 
advective transport in gaseous and liquid mixtures.  However, given that whole blood is a 
colloidal suspension, this description is not necessarily applicable and it is important that 
the transport system satisfy the principal assumption of the equation: that the ratio of 
volumetric transport for each phase is equal to its whole-blood volume fraction.  The 
primary technical aim of this research is to identify whole blood phenomena which 
violate this assumption and to invent the means for negating the deleterious effects of 
said phenomena.   
?̇?𝑡𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡𝑒𝑑 =  𝑐𝑖 ∗  ?̇?𝑊ℎ𝑜𝑙𝑒 𝐵𝑙𝑜𝑜𝑑 (1-1) 
The experimental apparatus which enables this investigation is described in Chapter 2.  
To support the accuracy of gathered data, this chapter provides detail regarding 
calibration of the sensor which controls the volumetric flow rate of whole blood. 
Furthermore, Chapter 2 contains an overview of microdevice components and an 
explanation of the process by which the fluidic circuit enables quantification of blood cell 
concentration. It should be noted that the device depicted in Chapter 2 is one of multiple 
unique designs utilized within this research.  Individual devices are detailed at the 
beginning of the appropriate chapter; the overview in Chapter 2 provides an explanation 
of the measurement methodology and understanding of how the circuit components 
function.   
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In Chapter 3, an initial microdevice design is introduced.  The overview of this device 
focuses on the device’s fluidic features while simultaneously providing an explanation of 
the sample analysis procedure.  Additionally, Chapter 3 details the experimental testing 
of this initial device design and provides some general comments regarding the results 
from this testing. 
 
The data generated in Chapter 3 is analyzed in Chapter 4.  Telling trends in the data are 
compared with established Hemorheological research as a means to generate working 
hypotheses for subsequent investigation.  Specifically, erythrocyte sedimentation is 
shown to be a likely cause of non-linearity observed in both RBC and WBC 
concentration measurements produced by the initial microdevice design.   
 
The working hypotheses generated in Chapter 4 are expanded upon in Chapter 5 where 
two secondary modes of transport are detailed.  The first phenomenon described is 
primarily applicable to white blood cell transport: Inhomogeneous distributions of white 
blood cells within the red blood cell matrix and the non-Newtonian properties of whole 
blood are expected to produce a piecewise shift in white blood cell transport due to the 
potential for a shift in average WBC channel-wise velocity which is disproportionate to 
the shift in bulk volumetric flow rate that occurs between the device-loading and cell-
dispensing processes.  The second phenomenon is an overriding consideration with 
regard to the sedimentation process: Shear has been shown to affect the sedimentation 
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rate with sedimentation rates equal to the ESR value under low-shear conditions, elevated 
sedimentation over a middle shear range, and a diminishing sedimentation rate above a 
peak-sedimentation shear rate.  While the data from Chapter 3 are strongly indicative of 
sedimentation effects, little indication of these secondary effects is afforded by 
experimental data and the phenomena presented in Chapter 4 are treated as cautionary 
considerations for the subsequent microdevice optimization. 
 
In Chapter 6, a gravity-negating transport domain is devised as a means to achieve 
accurate quantitation of red and white blood cell concentration via the cell-dispensing 
process.  The basic premise of the optimized cell-dispensing technology leverages the 
‘suspension’ region of a sedimenting body as a source from which untainted specimen 
can be siphoned.  It is shown that the relatively-stable spatial distribution of cells in that 
region and a gravity-perpendicular outlet velocity can produce an outlet transport rate that 
agrees with Equation (1-1).  After detailing the physical premise of the gravity-negating 
transport domain, an optimized microdevice, making use of this transport domain, is 
described.  As a conclusion to Chapter 6, the optimized microdevice is tested using a 
comparability-study format in order to gauge the efficacy of the gravity-negating 
transport domain.  Ultimately, the data generated by this device suggest a flaw in the 
operation of the revised transport domain. 
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Chapter 7 expands the understanding of whole blood dynamics within the cell-transport 
domain to include considerations for channel elements beyond the sedimenting domain.  
In particular, numerical simulation is used to demonstrate that the geometry of post-outlet 
passages can produce plasma recirculation which compromises the domain working 
principles.  In turn, a revised post-outlet configuration is simulated and shown to produce 
a stably, forward-moving outlet flow.  Subsequently, a new microdevice design is created 
which incorporates the revised post-outlet geometry.  Testing of this device yields RBC 
and WBC concentration measurements which are substantially more accurate than 
measurements generated by each of the previously-tested designs.    
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Chapter 2: Technical Overview of Experimental 
Apparatus and Microdevice Composition 
 
2.1 Experimental Apparatus 
The microdevices studied within this research are ‘passive’ meaning that the physical 
devices contain no internal mechanisms for propelling fluids or for performing cell 
detection.  To compensate for the lack of these functionalities, devices are coupled with 
an external pumping system which drives in-device flows and an optical-detection system 
which facilitates the quantitation of cell transport rates.  Interaction of the device with the 
pumping and optical detection systems are shown schematically in Figure 2-1.  As 
illustrated be this figure, a device facilitates three sequential operations—cell dispensing, 
cell processing, and cell focusing—and that each of these operations is complemented by 
the delivery of a fluid stream by the pumping system.   
 
Figure 2-1. Schematic overview of device interaction with pumping and optical-detection systems 
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The first fluid is a ‘pusher’ fluid which flows into the cell-dispensing portion of the 
microdevice and displaces the whole blood which is pre-loaded into that volume.  The 
second fluid is a processing reagent; ‘sphering’ solution which bloats red blood cells 
(spherical cells are more conducive to analysis) or ‘lysis’ solution which destroys red 
blood cells such that white blood cells are more readily detected.  The final fluid is a 
‘sheathing’ solution which is used to hydrodynamically focus (read: align cells in the 
channel-spanwise direction) cells at the point of detection. 
 
As focused cells pass through the point of detection, the optical detection system 
illuminates individual cells with a laser beam.  The transit of cells through the beam 
results in light scattering.  Select portions of the scattered light are focused onto 
photodiodes which produce an electric current proportionate to the intensity of received 
light.  This current is converted to a proportionate voltage using a trans-impedance 
amplifier.  As a cell passes through the laser beam, the intensity of scattered light rises, 
reaches a peak value corresponding to the peak beam intensity, and then falls as the cell 
exits the beam.  The resulting voltage pulse undergoes a peak-finding operation.  
Ultimately,  the optical detection system produces a list of the peak voltage values for 
cells which transit the beam during a ‘measurement’ operation.   
2.1.1 Fluid Pumping System 
The present research plan and the technology it aims to refine both rely upon knowledge 
of volumetric rates of in-device flows.  To satisfy those needs, the experimental apparatus 
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includes a pumping system which consists of four piston pumps which are individually 
actuated by stepper motors—Sapphire Engineering’s V-series pump.  Each of the four 
pumps dispenses fluid through a Sensirion LG16-series flow sensor which provides a 
digital reading of the volumetric flow rate with a characteristic response time of (40 [ms]) 
[13].  The flow readings serve as the output variable for a PID-controller which 
determines the rate of piston displacement based on the difference between sensor 
readings and the volumetric flow rates specified by an automated routine.  A diagram of a 
pump-controller loop is provided in Figure 2-2 which shows the flow of fluid from a 
piston pump, through a flow sensor, and an outlet flow which is ultimately supplied to a 
microdevice.   
 
Figure 2-2.  Diagram of PID-controlled pump 
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Also indicated in Figure 2-2  is the use of a calibration curve which converts digital 
readings from the flow sensor into units of volumetric flow [μL/min].  The calibration 
curves employed in this research were generated by the author using the process detailed 
in the next section.  Together, the PID controller and calibration curve ensure that a 
steady stream of fluid is delivered to the microdevice at the desired flow rate. To support 
the claimed knowledge of these flow rates, the following sections outline the sensor 
calibration procedure and provide a quantitative analysis of the PID controller 
performance.   
2.1.1.1 Sensor Calibration 
The accuracy of flow rates delivered to the device by the pumping system is dependent 
upon the quality of calibration curves used to calculate volumetric flow rates from digital 
flow sensor signals.  The calibration curves employed during this research were 
generated by actuating the piston pumps “open-loop” such that the linear displacement 
rate of the piston is equal to the volumetric flow rate of a calibration point divided by the 
cross-sectional area of the piston. This process was repeated for a series of flow rates 
which encompass the flow rates used within the measurement process.  The resulting 
data, relating digital sensor outputs to volumetric flow rate, were then fit with a second-
order polynomial which allows proportional, integral, and derivative gains to be 
calculated for all sensor readings encountered during operation of the pumping system. 
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2.1.1.2 Calibration Accuracy 
The piston diameter of V-series pumps are held to a (0.0001-inch) tolerance. For each of 
the four piston diameters within the V-series, that equates to less than (±0.25%) deviation 
from nominal for the cross-sectional area. Therefore, the calibration curve obtained 
through open-loop displacement of the pistons should fall within one-percent of the 
expected values; a suitable level of accuracy to support the work performed henceforth. 
2.1.1.3 PID-Control Tuning 
The transport processes investigated in this research require steady flow conditions.  To 
satisfy this requirement, the PID controller for each of the four pump assemblies was 
tuned to achieve minimal steady-state oscillation.  Additionally, minimization of settling 
time, or the time to reach steady state, was desired as delays in steadying of flow rates 
would hinder characterization of transient phenomena.  Table 1 provides a breakdown of 
PID performance for each pump at the flow rates found within this research.  In all cases, 
steady-state oscillation is within a ±2% margin and settling time is less than (5[s]).  
Table 1.  Summary of PID performance at key volumetric flow rates 
Pump (by fluid) Flow Rate [μL/min] S.S. Oscillation Settling Time 
Pusher 1.2  ±1.25% < 5[s] 
Pusher 0.4   ±1.75% < 5[s] 
Pusher 0.2   ±1.75% < 5[s] 
Pusher 0.1   ±1.75% < 5[s] 
Sphere 300   ±0.2% < 4[s] 
Sphere 40   ±0.5% < 4[s] 
Lyse 20   ±0.5% < 2[s] 
Sheath 1800   ±0.2% < 3[s] 
Sheath 900   ±0.2% < 3[s] 
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2.1.2 Optical Detection  
Quantification of in-device cell transport rates is facilitated by laser excitation of 
individual cells, projection of optically-significant conical segments of scattered light 
onto photodiodes, and peak detection of the resulting electronic signals.  As cells pass 
through a device’s point of measurement, the optical detection system produces two 
voltage values (one for each of two conical light segments analyzed) which correspond to 
the size and complexity of a transiting cell [14]; the use of these signal values are critical 
to categorization of white blood cell signals.  Signal categorization consists of 
‘clustering’ signal populations and classifying members of each cluster based on known 
scattering properties of cell types.  An illustration of signal clustering, provided by the 
experiment outlined in Chapter 3, is provided in Figure 2-3.   
 
Figure 2-3.  Color-coded classification of White Blood Cell subpopulations: Neutrophil (Blue), 
Lymphocytes (Red), Monocytes (Green), and Eosinophils (Yellow)  
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The signals shown in Figure 2-3 are the result of a White Blood Cell analysis for which 
Red Blood Cells were lysed, or made optically non-participating, such that the bulk of 
collected signals would represent WBCs.  After classifying these signals, signals from the 
target cell type can be grouped by an associated timestamp which is generated for each 
signal by the detection system.  The number of cells within a grouping divided by the 
timespan of analysis provides the transport rate. 
 
2.2 Microdevice Composition and Functionality 
Within this research, the microdevice design is altered for the purposes of 
experimentation.  However, the general architecture of the device will remain constant. In 
the following sections, this architecture is laid out in terms of the basic device 
components and the functionality they provide.  Parametric details and explanations of 
differences between the various microdevices are provided in the introduction of the 
chapters in which they appear.  Figure 2-4 provides an overview of the device 
composition using a representative microdevice.  In the figure, labels are provided for the 
device components which support the three primary measurement processes: cell 
dispensing, cell processing, and cell focusing. 
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Figure 2-4.  Architecture of a microdevice for quantitation of cell concentration in whole blood 
2.2.1 Cell Dispensing  
The most critical transport process with regard to cell concentration measurement is the 
controlled transport of blood cells within a whole blood sample which has been loaded 
into the microdevice prior to the device’s insertion into the experimental apparatus (or 
‘instrument’).  In each microdevice, there is a component which facilitates the cell-
dispensing process.  The cell-dispensing component contains an inlet which is exposed to 
the external surface of the device.  This inlet enables both manual introduction of the 
blood specimen and introduction of a pusher fluid the device so as to propel the whole 
blood sample. Additionally, the cell-dispensing component contains an outlet which 
allows propelled samples to pass into the cell-processing portion of the fluidic circuit.   
2.2.2 Cell Processing 
Whole blood flowing from the outlet of the cell-dispensing component must be modified 
with liquid reagents which complement light-scatter detection.  Basic reagents fall into 
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two categories: cell-lysing reagents which destroy RBCs to allow better detection of the 
less-concentrated WBCs and cell-sphering reagents which, true to name, transform RBCs 
from their typical discoid shape into spheres and enable determination of cell volume 
from the intensity of scattered light [15].  Thorough reaction between cells and reagents 
require both effective mixing (reduction of diffusion length) and suitable dwell time.  
These parameters are not straightforward design parameters. Rather, the mixing and 
dwell time are a function of the ratio of whole-blood flow to liquid-reagent flow, the 
manner in which these flows are combined, and the geometry through which the mixture 
flows.   
 
In each microdevice, there is a cell-processing component, generally a long channel of 
fixed cross-section, which facilitates the reaction between whole blood and the liquid 
reagent.  Both the channel and blood-reagent junction are detailed for each device in the 
introduction of the corresponding chapter.  The common features of each cell-processing 
component are: an inlet which is exposed to the external surface of the device to allow 
delivery of the processing reagent, a fluidic junction with the cell-dispensing component, 
and an outlet which leads into the cell-focusing component. 
2.2.3 Cell Focusing 
The final process to precede signal generation is the hydrodynamic focusing of processed 
cells.  Hydrodynamic focusing refers to the use of bounding fluid streams for alignment 
of entrained cells.  The particular form of cell focusing implemented in each of the 
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experimental devices involves the use of two streams of ‘sheathing’ fluid to compress the 
cell-reagent mixture by joining with the mixture at a cross-shaped junction.  The 
volumetric flow rate of the sheath streams, which are significantly greater than that of the 
mixture, meet with the cell-reagent mixture in such a way that a ‘ribbon’ of cells is 
formed; the width of this ‘ribbon’ is dictated by the mixture-to-sheath flow rate ratio and 
is configured to be significantly narrower than the laser beam which is focused on the 
processed-cell stream.  To an extent proportionate to the acceleration of cells passing 
through this ‘ribbon’, the cell-focusing circuit also enhances cell spacing in the 
streamwise direction.  Both the cell alignment and streamwise spacing of cells facilitated 
by the focusing component complements the detection process by ensuring cell-to-laser 
alignment and minimizing the frequency of simultaneous illumination of cells, 
respectively.   
2.3 Measurement Methodology 
The first step in the blood sample analysis process is manual injection of whole blood 
into the cell dispensing feature within the microdevice.  With blood loaded into the 
device, the microdevice is inserted into a mechanical alignment fixture which established 
a fluidic connection between microdevice fluid inlets and pump system outlets.  
Additionally, this fixture facilitates alignment of the optical-detection system with the 
point of detection within the device.  After the device is secured by the mechanical 
alignment fixture, an automated test routine begins.   
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The composition of an automated routine depends upon the cell concentrations which are 
of interest; an RBC concentration measurement utilizes a different pumping sequence, 
processing reagent, and flow rates than a routine for quantifying WBC concentration.   
The routine used in each experiment is provided in the appropriate overview section.  For 
each routine, there are the primary test segments: 
1. Set pump flow rates and allot suitable time for pumps to reach steady state 
2. Allot further time for establishing a steady-state transport condition within the 
cell-processing circuit 
3. Cell analysis via optical detection and subsequent calculation of cell transport 
rate 
Steps 1 & 2 of the routine are not altogether distinguishable with regards to the 
measurement process. Together the steps ensure unity between cell transport rate out of 
the cell-dispensing circuit and the transport rate which is observed at the point of 
detection.  With this quasi-steady condition established, the detected cell transport rate 
reflects the ‘dispensed’ cell transport rate such that the left-hand side of Equation (1-1) 
becomes known; a claim which is stated more formally in Equation (2-1) wherein, under 
steady-state conditions, the detected cell transport rate should be equal to the product of 
the pusher fluid volumetric flow rate and the concentration of the detected cell type 
within the whole blood sample. 
 
𝐷𝑒𝑠𝑖𝑟𝑒𝑑 𝑡ℎ𝑎𝑡, @𝑆. 𝑆.       ?̇?𝑑𝑒𝑡𝑒𝑐𝑡𝑒𝑑 =  𝑐𝑖 ∗  ?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑 (2-1) 
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@𝑆. 𝑆.       ?̇?𝑑𝑒𝑡𝑒𝑐𝑡𝑒𝑑 =  ?̇?𝑑𝑖𝑠𝑝𝑒𝑛𝑠𝑒𝑑 (2-2) 
 
As previously stated with regards to Equation (1-1), this research investigates and 
characterizes conditions which delineate the relationship stated in Equation (2-1) (i.e. 
Equation (2-1) is shown to be erroneous in many cases).  Independently, the equivalence 
between detected transport rate and dispensed transport rate during the quasi-steady 
transport state allows for characterization of the cell transport mechanisms taking place 
within the cell-dispensing component.  This equality, expressed in Equation (2-2) 
provides the basis for quantitative characterization of cell transport within this research.  
That is—the detected cell transport rates are assumed to reflect the rate of cell transport 
within (and ultimately out of) the cell dispensing feature of each microdevice.  The 
observed cell transport rates are used to validate hypotheses related the whole blood 
transport of red and white blood cells within the cell dispensing feature. 
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Chapter 3: Cell Transport in Vertically-Oriented 
Whole Blood Microchannel Flows 
 
The experimental investigations detailed in later chapters aim to identify the whole blood 
phenomena which are pertinent to the transport of red and white blood cells in creeping 
whole blood microflows.  This objective was motivated by the experimental datasets 
which are presented in this chapter.  Given that these data were acquired before the 
research objective was established, there are no hypotheses toward which the 
experimentation had been oriented.  Rather, the data were obtained as part of a study 
which compared blood cell concentration measurements obtained with a microdevice to 
measurements from an FDA-approved, reference instrument.  Such studies are commonly 
used in diagnostics development to gauge and inform the refinement of new technologies.  
Post-hoc analysis of the data from this ‘comparison study’ shows the microdevice 
measurements to be in error, yet seemingly-coherent.  In Chapter 4, the trends in 
microdevice measurements are used to generate working hypotheses which merit further 
investigation.  
3.1 Microdevice 
The microdevice used in this initial experiment is presented in Figure 3-1. The cell 
dispensing feature in this device consists of a straight, vertically-oriented (in operation, 
the normal vector of the device’s broad surface is perpendicular to gravity) channel 
possessing an inlet at its upper end and an outlet located at its lower end. The inlet to the 
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dispensing channel is exposed to the outer surface of the device while the outlet forms a 
fluid-fluid juncture with the cell processing channel.  The cell-processing channel lies in 
a separate plane from the cell-dispensing channel.  Where the channels intersect, the cell 
processing channel passes under the cell dispensing channel while a small, cylindrical 
channel connects the components.   
 
Figure 3-1.  Annotated illustration of the microdevice design utilized in the initial comparison study 
An isometric view of the juncture between the cell dispensing channel and cell 
processing channel is provided in Figure 3-2.  There, the cell processing channel, cell 
dispensing channel, and connecting channel are highlighted in dark grey, light grey, and 
white, respectively.  Additionally, flow directionality is indicated for the whole blood, 
and reagent entering the junction and the cell-reagent mixture exiting the junction.   
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Figure 3-2.  Isometric view of fluid-fluid junction between the cell dispensing and cell processing 
channels within the comparison study device 
The cell-reagent mixture which leaves the junction in Figure 3-2 flows onward, through 
the cell processing channel; the length of which was optimized to ensure thorough 
reaction of the cells.  Ultimately, the cell-reagent mixture arrives at the junction between 
the cell focusing feature and the cell-processing channel.  In this device, the cell-focusing 
feature and cell-processing channel are co-planar.  A schematic of this junction and the 
manner in which the cell-reagent mixture interacts which the sheath flows is provided in 
Figure 3-3.   
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Figure 3-3.  Schematic of the cell focusing feature used in each of the experimental devices 
Figure 7 does not accurately depict the progression of the cell-reagent-mixture stream 
through the cell focusing feature.  In reality, the width of the stream, previously referred 
to as the ‘ribbon’, gradually reduces as it approaches the point of measurement within the 
‘measurement channel’.  Rather than providing a true-to-life illustration of the flow 
through the measurement feature, Figure 3-3 is intended to aid in establishing the 
parameters which affect cell focusing in this design.  The important properties of the cell 
ribbon formed by the focusing feature are its width and location within the measurement 
channel.  The width of the ribbon must be small enough to avoid substantial variation in 
the intensity with which transiting cells are illuminated by the optical-detection system.  
Additionally, the ribbon must be centrally located within the measurement channel so 
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that quality optical signals can be obtained which are free from misalignment with the 
laser illumination and clear of interaction between the detection system’s illuminating 
laser and device’s channel edges. Because the flow within the cell focusing feature is 
low-Reynolds and because the geometry satisfies flat plate conditions, the width 
(𝑤𝑟𝑖𝑏𝑏𝑜𝑛) and lateral position (𝑥𝑟𝑖𝑏𝑏𝑜𝑛) of the cell ribbon can be accurately described 
with Hele-Shaw descriptions.  The equations for ribbon width and lateral position are 
given in Equation (3-1) and Equation (3-2), respectively.   
𝑤𝑟𝑖𝑏𝑏𝑜𝑛 =  𝑤𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑚𝑒𝑛𝑡 𝑐ℎ𝑎𝑛𝑛𝑒𝑙 ∗  (
?̇?𝑚𝑖𝑥𝑡𝑢𝑟𝑒
?̇?𝑠ℎ𝑒𝑎𝑡ℎ,𝑟𝑖𝑔ℎ𝑡 +  ?̇?𝑠ℎ𝑒𝑎𝑡ℎ,𝑙𝑒𝑓𝑡 +  ?̇?𝑚𝑖𝑥𝑡𝑢𝑟𝑒
) (3-1) 
𝑥𝑟𝑖𝑏𝑏𝑜𝑛  ≈  𝑤𝑟𝑖𝑏𝑏𝑜𝑛 ∗  (
?̇?𝑠ℎ𝑒𝑎𝑡ℎ,𝑟𝑖𝑔ℎ𝑡
?̇?𝑠ℎ𝑒𝑎𝑡ℎ,𝑟𝑖𝑔ℎ𝑡 + ?̇?𝑠ℎ𝑒𝑎𝑡ℎ,𝑙𝑒𝑓𝑡
) (3-2) 
In Equation (3-1), the width of the ribbon is stated to be equal to the width of the 
measurement channel multiplied by the ratio of the volumetric flow rate of the cell-
reagent mixture to the total volumetric flow rate through the measurement channel.  This 
description is primarily rooted in the conservation of mass; presuming that the flow 
profile is consistent over a majority of the channel’s span such that volumetric transport 
of each fluid can be assumed proportionate to the width that fluid occupies.  Equation (3-
2) is an approximation which assumes that the mixture flow rate is significantly less than 
the bounding flows and states that the ribbon will be positioned a distance from the right 
channel wall which is equal to the ratio of the right sheath’s volumetric flow rate divided 
by the total sheath volumetric flow rate. In situations where the mixture flow rate is 
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substantial, the ribbon’s centerline location would be offset from that predicted by 
Equation (3-2) by the ribbon’s half width.   
3.2 Measurement Routine 
For the data sets provided in the Results section of this chapter, red and white blood cell 
concentration measurements were generated using two separate measurement routines.  
In reality, each of the two measurement routines provided measurements of both RBC 
and WBC concentration with the primary difference between the two being the order in 
which the measurements were taken.  For routine 3A, red blood cell concentration was 
measured first, followed by a measurement of white blood cell concentration.  In routine 
3B, the order is reversed with white blood cell measurement preceding red blood cell 
measurement.   
 
Analysis of the datasets from routines 3A and 3B found a strong relationship between the 
WBC concentration measurements from routine 3A with the RBC concentration 
measurements from routine 3B.  Detailed analysis of this relationship is provided in 
Chapter 5.  Meanwhile, WBC concentration measurements from routine 3B and RBC 
concentration measurements from routine 3A were either consistent with the reference 
instrument or showed a substantially-lesser deviation from the reference measurement 
than in the opposite routine.  This finding was taken to imply that the source in device-
measurement error stemmed from transient phenomena (i.e. the transport might initially 
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be well-behaved before skewing from expected) and was an initial clue as to the 
dominate mechanism affecting microdevice measurements.   
 
Details for measurement routines 3A and 3B are provided in Appendix B.  The results 
presented in this chapter consist of data from the latter measurement of each routine.  In 
other words, the reported RBC concentration measurements correspond to measurement 
routine 3B while the reported WBC concentration measurements correspond to 
measurement routine 3A.    With that, it should be noted that the reported measurements 
were taken at nearly-identical time points from one another.  Conveniently, this lends 
credence to the hypotheses derived from the data because the RBC and WBC 
measurements can be treated as temporally concurrent. 
3.2.1 Additional Fluidic Technique for RBC Measurement 
The RBC-measurement routine used within the comparison study differs significantly 
both from the routines of other experiments and the measurement methodology outlined 
in Chapter 2.  Specifically, the RBC measurement routine includes an additional fluidic 
step which follows the establishment of steady transport within the cell processing 
channel but precedes RBC measurement.  During this extra step, the volumetric flow rate 
of the cell-processing reagent is set to zero.  As a result, the cell-fluid mixture in the cell 
processing channel undergoes a large shift in bulk velocity. As a result of this shift, the 
cell transport rate at the point of detection deviates from that of the initial steady state by 
the ratio of the initial and final bulk velocities; a relationship expressed in Equation (3-3). 
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?̇?𝑓𝑖𝑛𝑎𝑙 =  ?̇?𝑖𝑛𝑖𝑡𝑖𝑎𝑙  ∗  (
?̇?𝑓𝑖𝑛𝑎𝑙
?̇?𝑖𝑛𝑖𝑡𝑖𝑎𝑙
) (3-3) 
This technique was used in the comparison study to overcome the inability of an early 
version of the optical detection system to detect signals at the rate in which cells transited 
the point of measurement during the initial transport phase.  By scaling the transport rate, 
the shortcoming of the detection system was overcome while the resulting routine 
description, given in Equation (3-4), still allowed for back calculation of cell 
concentration. 
?̇?𝑑𝑒𝑡𝑒𝑐𝑡𝑒𝑑 =  𝑐𝑅𝐵𝐶 ∗  ?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑 ∗  (
?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑
?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑 +  ?̇?𝑠𝑝ℎ𝑒𝑟𝑖𝑛𝑔 𝑟𝑒𝑎𝑔𝑒𝑛𝑡
) (3-4) 
3.3 Experimental Procedure 
In the comparison study, twenty-two unique blood samples were measured with both the 
microdevice outlined in Section 3.1 and an Abbott CellDyn 3200—the reference 
instrument.  For each sample, a microdevice measurement was obtained with 
measurement routine 3B while eleven of the twenty-two samples were analyzed using 
routine 3A.  A test matrix, which includes reference RBC and WBC concentration 
measurements, is provided in Table 2. 
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Table 2.  Test matrix for the comparison of microdevice and reference instrument measurements 
 
 
3.4 Results 
3.4.1 RBC Concentration Measurements 
The RBC concentration of each sample was measured using both the microdevice and 
reference instrument.  The reference instrument provides a standard against which the 
accuracy of device measurements can be gauged.  A datum for each sample is provided in 
Figure 3-4 which shows a strong correlation between microdevice and reference-
instrument RBC-concentration measurements.  
Sample 1 2 3 4 5 6 7 8 9 10 11
Ref. RBC [M/uL] 2.06 3.33 3.55 3.65 3.67 4.01 4.60 4.76 4.86 5.42 6.25
Ref. WBC [k/uL] 3.45 3.71 3.73 3.21 11.60 3.29 10.80 26.20 4.23 7.08 5.11
3A           
3B           
Sample 12 13 14 15 16 17 18 19 20 21 22
Ref. RBC [M/uL] 4.47 2.22 3.79 2.46 6.29 3.21 1.98 4.05 2.80 3.04 3.82
Ref. WBC [k/uL] 6.14 23.00 3.07 12.40 0.96 5.06 3.90 12.50 8.94 18.20 7.80
3A           
3B           
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Figure 3-4.  Scatterplot illustrating the correlation between microdevice and reference instrument 
measurements of RBC concentration 
 
3.4.2 WBC Measurements 
The WBC concentration of samples (12-22) was measured using both the microdevice 
and reference instrument.  As with the RBC concentration measurements, the reference 
instrument allows the accuracy of microdevice WBC-concentration measurements to be 
quantitatively analyzed.  A correlation between the microdevice and reference WBC-
concentration measurements is provided in Figure 3-5.  Again, the correlation between 
microdevice and reference measurements is strong. 
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Figure 3-5.  Scatterplot illustrating the correlation between microdevice and reference instrument 
measurements of WBC concentration 
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Chapter 4: Cell Transport in Sedimenting Whole Blood 
 
Although the correlation plots presented in Chapter 3 validate the fundamental 
microdevice functionality, data contained therein are not representative of a clinically-
viable diagnostic technology.  At a minimum, a clinically-viable device must correlate to 
a reference instrument with a slope near one and intercept near zero such that 
measurements from the device can be treated as substantially-equivalent to its 
predecessor.  From a technical perspective, the non-unity slopes are particularly 
concerning given that the working principle of the microdevice, given in Equation (1-1), 
indicates that direct inference of cell concentrations should be achieved by the 
microdevice.  In other words, a lack of unity between microdevice and reference-
instrument measurements implies that the physical operation of the microdevice deviates 
significantly from the ideal case around which its functionality is derived.   
4.1 A Link between Microdevice-Measurement Bias and 
Whole Blood Composition 
Scrutiny of the data from Chapter 3 would eventually yield a set of hypotheses aimed at 
explaining the deviation of microdevice measurements from those of the reference 
instrument.  The extent of that deviation plays a key role in the formulation and 
validation of said hypotheses and is regularly referred to as a measurement’s bias.  
Within the context of this research, bias refers to the fractional difference of a 
microdevice measurement from the corresponding reference measurement.  The formula 
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for calculating bias is given in Equation (4-1) in terms of the concentration of cell-type ‘i’ 
(either RBC or WBC) as determined by the microdevice (𝑐𝑖,𝑚𝑖𝑐𝑟𝑜𝑑𝑒𝑣𝑖𝑐𝑒) and reference 
instrument(𝑐𝑖,𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒).  The bias of RBC (red-filled circles) and WBC (white-filled 
circles) measurements from the comparison study are plotted relative to reference RBC 
concentration in Figure 4-1. 
𝐵𝑖𝑎𝑠 =   (
𝑐𝑖,𝑚𝑖𝑐𝑟𝑜𝑑𝑒𝑣𝑖𝑐𝑒  −  𝑐𝑖,𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 
𝑐𝑖,𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒  
) (4-1) 
 
Figure 4-1.  RBC and WBC biases for the comparison study data 
Figure 4-1 contains a number of important observations regarding the microdevice 
measurements from the comparison study.  First, it indicates that the magnitude of bias is 
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strongly tied to the sample’s RBC concentration:  samples with high RBC concentration 
measured closer to reference than samples with lower concentration.  The plot also 
suggests that dominant bias sources affect RBCs and WBCs oppositely; resulting in an 
inversely-proportionate deviation from reference at lower RBC concentrations.  Because 
measurement bias appeared to be dependent upon a sample’s composition, it was 
theorized that sample measurements were influenced by whole blood phenomena.  
Additionally, the relationship between measurement bias and the sample’s RBC 
concentration suggested that the primary biasing phenomenon was itself a function of 
RBC concentration.   
4.2 A Working Hypothesis for Microdevice-Measurement Bias 
In considering possible causes of the bias illustrated in Figure 4-1, it was important that 
proposed theories agree with each of four key observations pertaining to that data.  These 
observations were: 
 Bias magnitude is strongly related to RBC concentration 
 RBCs and WBCs are affected oppositely; relatively equally 
 The bias-causing mechanism is likely a time-dependent phenomena 
 All samples follow a similar trend 
While the first three observations reveal something of the nature of the bias-causing 
mechanism, the fourth observation is equally important in that it suggests that device-
measurement bias is the product of a common blood property rather than a physiological 
condition (illness).  Given that, a hypothesis might be extracted from research of 
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fundamental whole blood research as opposed to linking device bias with a whole blood 
abnormality.  Acting upon that notion, a review of whole blood flows was conducted; 
focusing primarily on the Hemorheology literature compiled in [16].  Among the 
phenomena laid out in that text, erythrocyte sedimentation seemed an especially-likely 
cause of device-measurement bias.  
4.2.1 Erythrocyte Sedimentation 
Erythrocyte (read: red blood cell) sedimentation is an innate whole blood phenomenon in 
which the RBCs in a static volume of whole blood settle out of suspension.  This is a 
well-studied phenomenon due in part to its use as a general screen for illness [17] in the 
form of an erythrocyte sedimentation rate (ESR) test. An ESR test is conducted by injecting 
whole blood into a graduated glass tube having a (2.55[mm]) internal diameter [18].  The 
tube is then oriented such that the tube axis is aligned with gravity. Estimation of the ESR is 
then obtained by recording the position of the interface between the red-cell-containing 
volume and RBC-free plasma region which forms at the top of the tube at regular time 
intervals spanning the desired window of observation.    
 
In [19], high-resolution ESR recordings show the rate of interface advancement to be 
time-dependent.  Initially, the interface proceeds slowly (or not at all) while increasing in 
rapidity.  Eventually, this acceleration gives way to a period of constant interface motion.  
As the interface approaches the region of packed cells near the bottom of the tube, the 
rate of interface progress slows and eventually ceases when the cells reach a fully-packed 
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condition.  The author of [19] illustrates these ‘phases’ with a time plot of interface 
location; provided in Figure 4-2. 
 
Figure 4-2.  From [19]:  Cell-plasma interface location as a function of time for various hematocrit 
(HCT) values (from left to right: HCT = 26, 28, 34, 45) 
The data presented in Figure 4-2 is doubly supportive of RBC sedimentation as the 
primary bias-causing mechanism.  First of all, it shows the magnitude of RBC 
sedimentation to be time-dependent.  This is perhaps why device-measurement bias is 
more pronounced in measurements taken later in the course of routines.  Secondly, the 
author shows a consistent trend between hematocrit (HCT) and the sedimentation rate of 
a sample.  Assuming a rough equivalence between HCT and RBC concentration, this data 
confirms an increase in ESR with decreasing RBC concentration which again agrees with 
the observations from the comparison study.   
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One facet of the comparison study data not yet addressed is the effect of RBC 
sedimentation upon WBCs.  The device-measurement bias from the comparison study 
suggests that the primary bias-causing mechanism should affect WBCs in a manner 
opposite to RBCs.  In a case where that mechanism is RBC sedimentation, this implies a 
counter-settling of white blood cells.  Such a phenomenon is covered in [20] where the 
concentration of RBCs and WBCs in the upper half of a sedimentation tube was 
measured after varying durations of sedimentation.  The authors use these measurements 
to determine the rate at which WBCs transport along-with or counter-to RBCs during 
sedimentation.  Their findings showed that while sedimentation depleted RBCs from the 
upper half of tubes, the WBC concentration in that segment would rise.  Furthermore, the 
authors concluded that the rate of RBC depletion was “similar” to the rate of leukocyte 
anti-sedimentation, or ‘flotation’.  
4.3 The Effect of Erythrocyte Sedimentation upon the Rate of 
Cell Dispensing 
Further evidence supporting erythrocyte sedimentation as the dominant bias mechanism 
came from [21] wherein a population study was conducted which focused on the 
Erythrocyte Sedimentation Rate (ESR) of sickle-cell and ‘normal’ blood samples.  Plots 
from this publication, one of which is shown in Figure 4-3, illustrate the relationship 
between ESR and a patient’s hematocrit (solid volume fraction of blood).  The ESR data 
for ‘normal’ samples (bounded in grey) show a trend between ESR and hematocrit 
  41 
similar to the trend between RBC bias and sample RBC concentration: ESR increases as 
the solid volume fraction of blood decreases.    
 
Figure 4-3.  From [21]; Plot of ESR values for sickle-cell (diamond) and healthy (circle) samples  
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4.3.1 Microdevice Bias as a Function of ESR 
The trend in ESR relative to HCT, shown in Figure 4-3, resembled the RBC bias trend in 
Figure 4-1 to such an extent that an effort was made to tie a mathematical connection 
between the two.  The derivation begins by assuming that RBCs in the cell dispensing 
channel transit at a speed equal to the bulk flow velocity plus the ESR of a given sample; 
expressed mathematically in Equation (4-2). 
In order to relate the kinematic impact of ESR to the transport of cells in the cell-
dispensing channel, a relationship between channel-wise cell velocity and cell transport 
was established in Equation (A-6) (see Appendix A for derivation).  For the purposes of 
describing the impact of ESR upon RBC transport, Equation (A-6) can be rewritten as in 
Equation (4-3) where the rate of cell transport along the cell dispensing channel is stated 
as the product of the number of cells (𝑁) bounded by a control volume (which spans the 
entire channel cross-section) and the average channel-wise velocity (?̅?𝑠) of bounded 
cells, divided by the channel-wise length (∆𝑠) of said control volume. 
The RBC velocity approximation from Equation (4-2) can be substituted for the average 
stream-wise velocity term in Equation (4-3).  The resulting expression, Equation (4-4) 
describes the expected RBC transport for a sedimenting whole blood flow.  
 
?̅?𝑅𝐵𝐶 ≈  ?̅?𝑏𝑢𝑙𝑘 + 𝐸𝑆𝑅 (4-2) 
?̇? =  
𝑁 ∗ ?̅?𝑠
∆𝑠
 (4-3) 
  43 
In order to relate this description of RBC transport to the observed RBC bias, Equation 
(4-1) should be rewritten with the microdevice-measured RBC concentration replaced by 
the detected-RBC rate (?̇?𝑅𝐵𝐶,𝑑𝑒𝑡𝑒𝑐𝑡𝑒𝑑) divided by the volumetric flow rate of the pusher 
fluid(?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑); the formula used to calculate microdevice measurements. 
𝐵𝑖𝑎𝑠𝑅𝐵𝐶  =  
(
?̇?𝑅𝐵𝐶,𝑑𝑒𝑡𝑒𝑐𝑡𝑒𝑑
?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑
)
𝑐𝑅𝐵𝐶,𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒
− 1 
(4-5) 
An equation for the relationship between the expected RBC-measurement bias of a 
sedimentation-influenced measurement can then be obtained by substituting the right-
hand side of Equation (4-4) for the detected-RBC rate (?̇?𝑅𝐵𝐶,𝑑𝑒𝑡𝑒𝑐𝑡𝑒𝑑) in Equation (4-5); 
yielding Equation (4-6). 
𝐵𝑖𝑎𝑠𝑅𝐵𝐶,𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑  =  
𝑁𝑅𝐵𝐶 ∗ (?̅?𝑏𝑢𝑙𝑘 + 𝐸𝑆𝑅)
∆𝑠
?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑  ∗  𝑐𝑅𝐵𝐶,𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒
− 1 (4-6) 
Equation (4-6) can be simplified by expanding the terms in the ratio’s denominator using 
the appropriate terms present in the numerator.   The equalities used to make this 
expansion are provided in Equations (4-8) and (4-9) while the expanded form is given in 
Equation (4-7). 
𝐵𝑖𝑎𝑠𝑅𝐵𝐶,𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑  =  
𝑁𝑅𝐵𝐶 ∗ (?̅?𝑏𝑢𝑙𝑘 + 𝐸𝑆𝑅)
∆𝑠
(
𝑁𝑅𝐵𝐶
𝐴𝑐 ∗ ∆𝑠
) ∗  ?̅?𝑏𝑢𝑙𝑘 ∗ 𝐴𝑐
− 1 (4-7) 
?̇?𝑅𝐵𝐶 =  
𝑁 ∗ (?̅?𝑏𝑢𝑙𝑘 + 𝐸𝑆𝑅)
∆𝑠
 (4-4) 
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?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑  =  ?̅?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑 ∗  𝐴𝑐 =  ?̅?𝑏𝑢𝑙𝑘 ∗  𝐴𝑐 (4-8) 
𝑐𝑅𝐵𝐶,𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 =  (
𝑁𝑅𝐵𝐶
𝐴𝑐 ∗  ∆𝑠
) (4-9) 
 
Cancellation of terms in Equation (4-7) reveals a simple relationship between the 
predicted RBC-measurement bias and the ESR of a blood sample.  This relationship, 
given in Equation (4-10) states that the bias of ESR-affected measurements should be 
equivalent to the sample’s ESR divided by the bulk flow velocity within the cell 
dispensing channel. 
𝐵𝑖𝑎𝑠𝑅𝐵𝐶,𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑  =  
𝐸𝑆𝑅
?̅?𝑏𝑢𝑙𝑘
 (4-10) 
 
4.3.2 Inferring ESR Values from Device-Measurement Bias 
If the biases of device measurements within the comparison study were the product of 
erythrocyte sedimentation, the data in Figure 4-1 should reflect the relationship in 
Equation (4-10).  Though the ESR for each sample is unknown, both the bulk blood flow 
velocity and measurement biases are known.  A simple rearrangement of Equation (4-10) 
yields Equation (4-11) which states that an ESR value can be calculated, or inferred, as 
the product of RBC-measurement bias and the bulk blood flow velocity.   
𝐸𝑆𝑅𝑖𝑛𝑓𝑒𝑟𝑟𝑒𝑑  =  𝐵𝑖𝑎𝑠𝑅𝐵𝐶 ∗  ?̅?𝑏𝑢𝑙𝑘 (4-11) 
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The bulk blood flow velocity within the cell dispensing channel is equal to the volumetric 
flow rate of pusher fluid (?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑) divided by the channel’s cross-sectional 
area(𝐴𝑐).  The substitution of these parameters for the bulk-velocity term in Equation (4-
11) yields Equation (4-12).   
𝐸𝑆𝑅𝑖𝑛𝑓𝑒𝑟𝑟𝑒𝑑  =  𝐵𝑖𝑎𝑠𝑅𝐵𝐶 ∗  (
?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑 
𝐴𝑐
) (4-12) 
For the comparison-study microdevice, the cell dispensing channel was (0.3[mm]) deep, 
and (1.0[mm]) wide while the volumetric flow rate of pusher fluid was (1[mm
3
/min]) or 
(60[mm
3
/hr]).  Thus, the coefficient relating ESR and RBC bias is (165.3 [mm/hr]) for 
the comparison study data set.  The product of each microdevice-RBC-measurement bias 
with this coefficient is plotted in Figure 4-4 alongside the bounding-box margins from 
Figure 4-3.  
 
Figure 4-4.  Plot of ESR values inferred from the comparison study bias (red-filled circles) with the 
bounding box from Figure 4-3 
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The demonstrated agreement between inferred ESR values and the bounding box of ESR 
values published in [21]  further the support for experimental investigation of the effects 
of RBC sedimentation upon cell transport in the cell dispensing feature. However, prior 
to formulating a plan to address sedimentation bias, it was important to provide a similar 
treatment to describing WBC transport in the cell dispensing channel as was given for the 
transport of RBCs. 
4.4 WBC Transport in Sedimenting Whole Blood 
Leukocyte flotation, or anti-sedimentation, refers to the upward (opposite gravity) 
transport of white blood cells in sedimenting whole blood.  As the sedimenting body is 
primarily dominated by red blood cell motion, it should be possible to leverage the 
previously-developed description of RBC transport to describe the transport of white 
blood cells.  Additionally, if flotation were the dominate mechanism of WBC transport, 
the microdevice-WBC-measurement biases from the comparison study should agree with 
this description. 
4.4.1 Description of WBC Flotation 
The primary assumption of this derivation is that WBCs will flow uninhibitedly within 
the plasma phase of sedimenting whole blood.  As the volume fraction of red blood cells 
can exceed (50%), this is likely a flawed assumption.  However, a description of WBC 
flotation based on this assumption will enable an initial assessment of WBC transport 
based on the comparison-study data.  Derivation of the WBC-flotation description begins 
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with a conservation equation, Equation (4-13).  It states that the volumetric flow rate of 
plasma (?̇?𝑝𝑙𝑎𝑠𝑚𝑎) is equal to the bulk volumetric rate (?̇?𝑏𝑢𝑙𝑘)  through the cell-dispensing 
channel minus the volumetric flow rate of RBCs, (?̇?𝑅𝐵𝐶).  As a note: all flow conditions 
apply to the WBC-measurement phase of Routine 3A.   
?̇?𝑝𝑙𝑎𝑠𝑚𝑎 =  ?̇?𝑏𝑢𝑙𝑘 −  ?̇?𝑅𝐵𝐶 (4-13) 
Next, the effects of RBC sedimentation must be introduced.  The volumetric flow rate of 
sedimenting RBCs can be stated as the product of the mean cell volume (𝑀𝐶𝑉) and the 
RBC-transport rate, (?̇?𝑅𝐵𝐶).  This relationship, shown in Equation (4-14), can then be 
substituted into Equation (4-13) to give Equation (4-15).   
?̇?𝑅𝐵𝐶 =  𝑀𝐶𝑉 ∗ ?̇?𝑅𝐵𝐶 (4-14) 
?̇?𝑝𝑙𝑎𝑠𝑚𝑎 =  ?̇?𝑏𝑢𝑙𝑘 −  𝑀𝐶𝑉 ∗  ?̇?𝑅𝐵𝐶 (4-15) 
As outlined in the prior sections, it is suspected that the RBC-transport rate deviates from 
Equation (1-1) by an amount equal to a blood sample’s ESR divided by the bulk flow 
velocity of whole blood within the cell-dispensing channel.  Therefore, the RBC-
transport-rate term in Equation (4-15) can be replaced with the product of the right-hand 
side of Equation (1-1) multiplied by a unity scalar which is offset by said ratio.  The 
result of this substitution is given in Equation (4-16) wherein the prescribed formula for 
RBC-transport rate is bracketed. 
?̇?𝑝𝑙𝑎𝑠𝑚𝑎 = ?̇?𝑏𝑢𝑙𝑘 −  𝑀𝐶𝑉 ∗ [𝑐𝑅𝐵𝐶 ∗ ?̇?𝑏𝑢𝑙𝑘 ∗ (1 +  
𝐸𝑆𝑅
?̅?𝑏𝑢𝑙𝑘
)] (4-16) 
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At this point, the derivation diverts in order to modify the focus of Equation (4-16). 
Whereas this equation describes the volumetric flow rate of plasma, what is desired is a 
description of expected WBC-measurement bias based on known quantities.  This shift 
begins with the WBC-analog of Equation (4-3): Equation (4-17).  Equation (4-17) states 
that the WBC-transport rate within a straight channel of uniform cross section (here, the 
cell-dispensing channel) can be calculated as the product of the total number (𝑁) and 
average channel-wise velocity (?̅?𝑠,𝑊𝐵𝐶) of WBCs bounded by a control volume divided 
by the channel-wise length (∆𝑠) of said volume.   
?̇?𝑊𝐵𝐶 =  
𝑁 ∗  ?̅?𝑠,𝑊𝐵𝐶
∆𝑠
 (4-17) 
The assumption of uninhibited WBC transport allows channel-wise WBC velocity to be 
replaced with a plasma velocity (?̅?𝑝𝑙𝑎𝑠𝑚𝑎) term.  In turn, the plasma velocity term can be 
substituted by the volumetric flow rate of plasma (?̇?𝑝𝑙𝑎𝑠𝑚𝑎) divided by the fluid-fraction 
of the channel’s cross-sectional area; calculated as the complement of hematocrit (𝐻𝐶𝑇′) 
multiplied by the channel area (𝐴𝑐).  The result of these substitutions is given in Equation 
(4-18). 
?̇?𝑊𝐵𝐶 =  
𝑁 ∗ (
?̇?𝑝𝑙𝑎𝑠𝑚𝑎
𝐴𝑐 ∗ 𝐻𝐶𝑇′
)
∆𝑠
 
(4-18) 
Equation (4-18) can be reduced to a simpler form by combining (𝑁), (∆𝑠), and (𝐴𝑐) to 
yield a WBC-concentration term (𝑐𝑊𝐵𝐶).  In turn, the (?̇?𝑝𝑙𝑎𝑠𝑚𝑎) term can be isolated to 
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give Equation (4-19).  Subsequently, Equation (4-19) can be substituted into Equation (4-
16) to give Equation (4-20). 
?̇?𝑝𝑙𝑎𝑠𝑚𝑎 =  
?̇?𝑊𝐵𝐶 ∗ 𝐻𝐶𝑇′
𝑐𝑊𝐵𝐶
 (4-19) 
?̇?𝑊𝐵𝐶 ∗ 𝐻𝐶𝑇′
𝑐𝑊𝐵𝐶
=  ?̇?𝑏𝑢𝑙𝑘 −  𝑀𝐶𝑉 ∗ [𝑐𝑅𝐵𝐶 ∗ ?̇?𝑏𝑢𝑙𝑘 ∗ (1 +  
𝐸𝑆𝑅
?̅?𝑏𝑢𝑙𝑘
)] (4-20) 
Distributing the WBC-concentration and hematocrit-complement terms in Equation (4-
20) gives way to Equation (4-21).  Furthermore, dividing both sides of Equation (4-21) 
by the ideal WBC-transport rate (?̇?𝑊𝐵𝐶,𝑖𝑑𝑒𝑎𝑙 𝑜𝑟 𝑐𝑊𝐵𝐶 ∗  ?̇?𝑏𝑢𝑙𝑘) yields Equation (4-22).  
The WBC-concentration and bulk volumetric flow rate terms in the right-hand side of 
Equation (4-22) cancel. Additionally, the mean-cell-volume, and RBC-concentration 
terms can be replaced with a hematocrit (𝐻𝐶𝑇) term.   
?̇?𝑊𝐵𝐶 =  
𝑐𝑊𝐵𝐶 {?̇?𝑏𝑢𝑙𝑘 −  𝑀𝐶𝑉 ∗ [𝑐𝑅𝐵𝐶 ∗ ?̇?𝑏𝑢𝑙𝑘 ∗ (1 + 
𝐸𝑆𝑅
?̅?𝑏𝑢𝑙𝑘
)]}
𝐻𝐶𝑇′
 
(4-21) 
(
?̇?𝑊𝐵𝐶
?̇?𝑊𝐵𝐶,𝑖𝑑𝑒𝑎𝑙
) =  
𝑐𝑊𝐵𝐶 {?̇?𝑏𝑢𝑙𝑘 −  𝑀𝐶𝑉 ∗ [𝑐𝑅𝐵𝐶 ∗ ?̇?𝑏𝑢𝑙𝑘 ∗ (1 +  
𝐸𝑆𝑅
?̅?𝑏𝑢𝑙𝑘
)]}
𝑐𝑊𝐵𝐶 ∗  ?̇?𝑏𝑢𝑙𝑘 ∗ 𝐻𝐶𝑇′
 (4-22) 
(
?̇?𝑊𝐵𝐶
?̇?𝑊𝐵𝐶,𝑖𝑑𝑒𝑎𝑙
) =  
{1 − [𝐻𝐶𝑇 ∗ (1 +  
𝐸𝑆𝑅
?̅?𝑏𝑢𝑙𝑘
)]}
𝐻𝐶𝑇′
 (4-23) 
Because microdevice measurements are linearly related to the WBC-transport rate, the 
ratio of actual to ideal WBC-transport rate is equal to the ratio of actual to ideal 
microdevice measurements.  Therefore, Equation (4-23) can be rewritten as a description 
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of WBC-measurement bias simply by subtracting (1) from its right-hand side.  This 
relationship is given in Equation (4-24). 
𝐵𝑖𝑎𝑠𝑊𝐵𝐶 =  
{1 − [𝐻𝐶𝑇 ∗ (1 +  
𝐸𝑆𝑅
?̅?𝑏𝑢𝑙𝑘
)]}
𝐻𝐶𝑇′
− 1 
(4-24) 
Subsequent cancellation of terms simplifies the expression, resulting in 
Equation (4-25). 
 
𝐵𝑖𝑎𝑠𝑊𝐵𝐶 =  −
𝐻𝐶𝑇 ∗ (
𝐸𝑆𝑅
?̅?𝑏𝑢𝑙𝑘
)
1 − 𝐻𝐶𝑇
 
(4-25) 
  
4.4.2 Comparison of WBC-Measurement Bias with Flotation Model 
In Section 4.2.2, RBC-measurement biases were used to infer ESR values for the samples 
analyzed during the comparison study.  In turn, these inferred-ESR values can be used to 
calculate an expected WBC-measurement bias using Equation (4-25).  Both the inferred-
ESR and hematocrit (HCT) values in this expression are sample-dependent parameters 
with the latter being provided by the reference instrument.  The bulk velocity is a fixed 
quantity calculated as the bulk volumetric flow rate of blood during the WBC-
measurement phase of routine 3A divided by the cell-dispensing channel’s cross-
sectional area.  The calculated bias data are plotted in Figure 4-5 alongside the measured 
bias data from the comparison study. 
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Figure 4-5.  Plot of calculated and measured WBC-measurement bias (from comparison study) 
The calculated-bias data (black diamonds) in Figure 4-5 demonstrate a trend that 
resembles that of the actual measurement bias (white circles) in that each dataset shows 
increasingly-negative bias as the hematocrit of measured samples decreases.  However, it 
is not reasonable to claim good general agreement between the calculated and measured 
bias.  The disagreement between the sets could stem from any number of causes though it 
is important to note that the measured bias often exceeds the calculated bias. If the 
assumption of uninhibited WBC flotation were the cause of discrepancy, the opposite 
would be expected.  Given that, there are two possible categories of issue with the 
analysis used to generate Figure 4-5. 
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One possible flaw in the post-hoc analysis of the comparison study data lies in the 
physical separation of observations of RBC and WBC transport.  Optimally, 
measurement of transport rates for the two cell types would occur simultaneously.  As the 
data sets for RBCs and WBCs have, to this point, been generated using separate test 
routines, the flow conditions pertaining to them are not identical.  Consider, for instance, 
that the flow rate through the cell-dispensing channel may alter the sedimentation rate of 
RBCs.  Under such circumstance, the application of ESR values extracted from RBC-
measurement conditions cannot be validly applied to a description of WBC transport.   
 
The second issue to be considered is the potential for additional phenomena affecting 
RBC and or WBC transport.  The following chapter details two phenomena which would 
have likely played a role in the cell-dispense rates within the initial microdevice.   
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Chapter 5: Pertinent Phenomena for Cell Transport in 
Whole Blood Microflows 
 
5.1 Effects of Device Loading 
A major misgiving with regard to prior descriptions of cell transport is the assumption 
that blood occupying the cell-dispensing channel is unaltered at the beginning of a 
measurement routine.  It is important to recognize that initiation of a test routine is 
preceded by a potentially-significant transport process: device loading.  In order to 
establish the technical significance of device loading, a ‘proper’ load is defined as the 
establishment of a steady transport within the cell-dispensing channel. Assume that the 
vessel (e.g. a large-bore pipette) which facilitates sample loading ensures unity between 
the injected cell transport rate (?̇?𝑙𝑜𝑎𝑑𝑖𝑛𝑔) and the product of outlet bulk flow 
rate(?̇?𝑙𝑜𝑎𝑑𝑖𝑛𝑔), and reference cell concentration(𝑐𝑖,𝑟𝑒𝑓), stated formally in Equation (5-1).   
?̇?𝑙𝑜𝑎𝑑𝑖𝑛𝑔 =  𝑐𝑖,𝑟𝑒𝑓 ∗  ?̇?𝑙𝑜𝑎𝑑𝑖𝑛𝑔 (5-1) 
Again adopting Equation (4-3), the loading-phase transport rate can be treated as the 
product of channel-wise linear cell concentrations (
𝑁
∆𝑠
) and average channel-wise cell 
velocity (?̅?𝑠) within the cell-dispensing channel; Equation (5-2).  Here, it is important to 
consider the cell-dispensing channel as a succession of control volumes between which 
the channel-wise concentration and average channel-wise velocity may vary.  Yet, by the 
definition of a proper load, these variables must satisfy Equation (5-2) at the conclusion 
of the loading process.   
  54 
(
𝑁𝑖
∆𝑠
∗ ?̅?𝑖,𝑠)
𝑐.𝑣.
=  𝑐𝑖,𝑟𝑒𝑓 ∗  ?̇?𝑙𝑜𝑎𝑑𝑖𝑛𝑔 (5-2) 
As blood flows through the cell-dispensing channel during loading, the mechanics of 
blood flow can alter the distribution of cells within the cross-section of the channel.  The 
mechanics of the alteration are not the immediate focus. However, the consequences of 
redistribution can be explained by one example: leukocyte margination, here.  Leukocyte 
(WBC) margination is a phenomenon linked with hemodynamic and rheological 
mechanisms which displace WBCs within the cross-section of a whole blood capillary 
flow [22].  In terms of the device-loading process, the redistribution of WBCs is of 
concern because of the relationship between cross-sectional position and channel-wise 
velocity.  More to the point, satisfaction of Equation (2-1) requires a specific relationship 
between loading-phase and dispensing-phase cell motion. To show this relationship, an 
analysis will be performed for one of the control volumes occupying the cell-dispensing 
channel.  For this control volume, the ideal dispensing-phase cell transport rate is given 
by Equation (2-1) which can be rewritten in the form of Equation (5-2) as Equation (5-3). 
𝑁𝑖
∆𝑠
∗  ?̅?𝑖,𝑠,𝑑𝑖𝑠𝑝𝑒𝑛𝑠𝑖𝑛𝑔 =  𝑐𝑖,𝑟𝑒𝑓 ∗  ?̇?𝑑𝑖𝑠𝑝𝑒𝑛𝑠𝑖𝑛𝑔 (5-3) 
Assuming the distribution of cells within the channel is constant  between the end of the 
loading and  beginning of the dispensing phase, (
𝑁𝑖
∆𝑠
) terms can be treated as equal and 
Equations (5-2) & (5-3) can be combined to form Equation (5-4). 
?̇?𝑙𝑜𝑎𝑑𝑖𝑛𝑔
?̇?𝑑𝑖𝑠𝑝𝑒𝑛𝑠𝑖𝑛𝑔
 =  
?̅?𝑖,𝑠,𝑙𝑜𝑎𝑑𝑖𝑛𝑔
?̅?𝑖,𝑠,𝑑𝑖𝑠𝑝𝑒𝑛𝑠𝑖𝑛𝑔
 (5-4) 
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Equation (5-4) states a necessary condition for the relevance of Equation (2-1): the ratio 
of average cell velocity must be proportionate to the ratio of bulk volumetric flow rate 
when comparing the loading and dispensing phases.  This condition is innately true of 
molecules transported in homogeneous solutions; a process which is often given 
descriptions similar to Equation (2-1).  However, whole blood is a mixture for which 
Equation (5-4) is only conditionally applicable. With non-uniform WBC distributions for 
instance, Equation (5-4) would be necessarily satisfied if the normalized velocity profiles 
for the loading and dispensing transport phases were identical.  This would be expected 
for creeping, Newtonian flow conditions.  However, whole blood exhibits non-
Newtonian behavior under low shear conditions [23] and a yield stress near stasis [24] 
[25].  As such, the change in bulk flow rate between device loading and cell dispensing 
will result in a change in the cross-sectional velocity profile.  Consequently, cells do not 
necessarily experience deceleration which is proportionate to the change in bulk 
volumetric flow rate.  Depending on the extent of cell inhomogeneity, this shift in 
velocity profile may significantly violate Equation (5-4) and, in turn, invalidate Equation 
(2-1) as a description of the cell-dispensing process.   
5.2 Sedimentation in Shearing Whole Blood 
In Chapter 4, erythrocyte sedimentation was shown to be a three-phase process.  In the 
initial phase, progress of the cell-plasma interface is slow but gradually increasing in 
linear velocity. The cause of this increase in sedimentation rate during the initial, or ‘lag’, 
phase is the aggregation of red blood cells which increases the permeability of the 
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blood’s solid phase such that a constant gravitational force produces greater upward 
transport of plasma [26].  For a majority of blood samples, aggregation is a reversible 
process [27]; aggregates formed under low-shear conditions will disaggregate under 
elevated shear [28].  The dependence of aggregation upon shear conditions raises 
questions regarding the previous descriptions of ESR-biased cell transport: how does the 
presence of shear in the duct flow within the microdevice affect sedimentation? 
 
If sedimentation were strictly proportional to aggregation, it would be sensible to expect 
that any shear which inhibits aggregation should in turn reduce the rate of sedimentation.  
Oppositely, in [29], it was shown that the shear-ESR relationship is complex; low shear 
rates do not affect ESR (0-10
-3
[s
-1
]) but increasing levels of shear will lead to an 
enhancement of ESR (10
-3
-10
-1
[s
-1
]).  Beyond a peak sedimentation rate, corresponding to 
a shear rate of approximately (10
-1
[s
-1
]), the sedimentation rate begins to reduce and 
eventually diminishes altogether (10
-1
-10
1
[s
-1
]).  This relationship is illustrated in Figure 
5-1 which contains experimental data for ESR of whole blood samples of varying 
hematocrit under an array of shear conditions.   
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Figure 5-1.  From [29]: Plot of experimental data demonstrating the shear dependence of ESR 
The shear-ESR relationship illustrated in Figure 5-1 might help to explain the major 
shortcomings of prior cell transport descriptions:  overestimating ESR from RBC bias 
and misestimating WBC bias from said ESR estimates.  The ESR values inferred from 
RBC bias pertain to a sedimenting shear flow. Thus, if flow conditions are such that 
ESR-elevating shear rates are present, inferred-ESR values might exceed the published 
ESR values which pertain to static whole blood transport.  With respect to the inability to 
use inferred-ESR values to predict WBC bias: the difference in flow rate between the 
RBC and WBC measurements will alter the velocity profile and, in turn, the shear acting 
upon the flow.  Consequently, it would be faulty to apply inferred-ESR values to WBC 
measurements from the comparison study as the shear-enhanced sedimentation should 
have affected the two measurements to different extents.   
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Chapter 6: A Gravity-Bias-Free Transport Domain 
 
A primary motivation of this research is to advance healthcare through the development 
of technologies which could enhance the scope of tests available at the point of care.  The 
experimental testing of devices in Chapters 3 and 4 demonstrated the profound effects of 
gravity upon cell transport in creeping whole blood flows.  The scope of design 
considerations were then expanded through discussion of key, secondary phenomena in 
Chapter 5.  In order to satisfy the research objective, these findings should be converted 
into meaningful device revisions which give rise to a cell-dispensing technology which is 
unbiased by gravitational effects.  In this chapter, an optimized, gravitationally-unbiased 
transport domain is developed and tested within a device such that performance of this 
revised device can be compared with that of the initial, gravity-biased device. 
6.1 Cell-Dispensing Domain 
The optimized transport domain consists of a primary blood-holding volume having an 
inlet for blood loading and blood propulsion (propulsion is again provided by an external 
pump which delivers ‘pusher fluid’ at a controlled rate) and an outlet which links the 
holding volume with an adjoining channel which, in turn, links the cell-dispensing circuit 
with a cell-processing circuit.  As the transport through the domain outlet will define the 
‘cell-dispensing’ accuracy of this domain, cell distributions and motion in the ‘transition 
control volume’ which links the blood-holding domain to post-outlet channels is of key 
interest.  Each of the three key domain elements (blood-holding volume, outlet, and 
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transition control volume) is illustrated in Figure 6-1 which provides a detailed view of 
the revised cell-dispensing domain.  
 
 
Figure 6-1  Detailed view of blood-holding volume, outlet, and transition control volume 
6.1.1 Principles of Operation 
The blood-holding element, which acts as a sustained source for gravitationally-
unaffected blood, is a straight, vertically-oriented channel having a relatively large (read: 
non-micro), uniform cross section.  Within this element, where the bulk flow velocity 
will be on the order of an average ESR value (~30 [mm/hr]), cell transport is dominated 
by sedimentation.  As such, this portion of the transport domain will exhibit the 
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characteristic phase regions found within a sedimenting medium: packing, suspension, 
and supernatant.  For whole blood, these phase regions are packed cells, pristine (whole) 
blood, and plasma, respectively.  The spatial relationship of these phases is shown in 
Figure 6-2 wherein the composition of the sedimenting domain is shown to be a function 
of time.  At the outset of the sedimentation process, the entire height of the sedimenting 
body is filled with homogeneously-distributed cells. With time, a cell-free plasma region 
forms above the cell suspension while a packed-cell region forms below.  The interfaces 
separating these phases are represented by the solid and dashed curvilinear lines, 
respectively.   
 
Figure 6-2  Time-lapse diagram of phases within sedimenting whole blood 
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Before the upper and lower interfaces converge, the sedimenting domain contains a 
region of whole blood which, although cells are moving in the vertical axis, should have 
a spatial composition which is reasonably similar to the blood composition at (t=0).  This 
sustained spatial distribution can be leveraged as part of a means to achieve 
gravitationally-unbiased cell transport. 
6.1.2 Circumventing Gravitational Dispensing Bias 
Within the sedimenting domain, red and white blood cells are transported in the gravity-
parallel direction independently of bulk advection due to the overriding sedimentation 
process.  In order for that gravity-parallel motion to not exaggerate or inhibit transport of 
cells across the outlet, the normal vector of the sedimenting domain’s outlet surface is 
made to be perpendicular to gravity.  Since the outlet’s normal vector defines the 
effective streamwise flow direction of dispensed cells, the vertical-axis motion brought 
about by gravity does not affect the channel-wise velocity of cells as they exit the blood-
holding domain. 
 
The transition control volume dictates the cell dispense rate in that the cells transported 
across the outlet plane are subsequently transported through the adjoining channel and 
into the cell-processing portion of the device.  Although the exact velocity distribution 
within this control volume will vary with sample rheology, domain geometry, and bulk 
flow rate, the rate of cell dispensing (?̇?𝑑𝑖𝑠𝑝𝑒𝑛𝑠𝑒𝑑) can be controlled with careful 
management of the bulk volumetric flow rate through the outlet and maintenance of the 
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spatial distribution of cells adjacent to the outlet.  Mathematically, this conjecture is 
confirmed by the following descriptions of volumetric flow rate and particle transport 
rate for elements on the outlet surface: 
𝑑?̇? = 𝑢?̂?,𝑏𝑢𝑙𝑘 ∗ 𝑑𝐴,   𝑑?̇?𝑐𝑒𝑙𝑙𝑠 =  
𝑐𝑐𝑒𝑙𝑙 ∗  𝑑𝑉 ∗  ?̅??̂?,𝑐𝑒𝑙𝑙𝑠
𝑑𝑠
   
 
 𝑑?̇?𝑐𝑒𝑙𝑙𝑠 =  𝑐𝑐𝑒𝑙𝑙 ∗  ?̅??̂?,𝑐𝑒𝑙𝑙𝑠 ∗ 𝑑𝐴  (6-3) 
 
If the spatial distribution of cells within the transition control volume is sufficiently 
representative of the blood sample ( 𝑐𝑐𝑒𝑙𝑙 =  𝑐𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒) and the outlet-normal interphase 
motion is negligible (?̅??̂?,𝑐𝑒𝑙𝑙𝑠 = 𝑢?̂?,   𝑏𝑢𝑙𝑘) Equation (6-3) can be re-written as Equation 
(6-4) the surface integral of which reflects a bias-free cell-dispensing operation. 
𝑑?̇?𝑑𝑖𝑠𝑝𝑒𝑛𝑠𝑒𝑑 =  𝑐𝑟𝑒𝑓 ∗  𝑑?̇?  (6-4) 
Here, interphase motion is minimized by maintaining a gravity-perpendicular outlet 
vector.  Meanwhile, reference-unity of the outlet-adjacent cell concentration will be 
dictated by the transport taking place within the blood-holding volume. The latter 
consideration, here, is the facet of device operation to which the whole blood phenomena 
described in Chapter 5 are most pertinent.  The following section discusses the way in 
which both leukocyte margination and shear-enhanced sedimentation factor into the 
blood-holding domain design. 
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6.2 Sustaining Cell Concentrations  
Transport within the sedimenting domain must be managed in such a way as to ensure 
that red and white blood cell concentrations within the transition control volume are 
representative of the whole-blood sample being analyzed, (𝑐𝑐𝑒𝑙𝑙 =  𝑐𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒).  To that 
end, there is a number of design constraints concerning the whole-blood phenomena 
detailed in Chapter 5:.  The following sections provide a context for discussion of 
concentration ‘maintenance’ and discuss the particular way in which the effects of each 
prescribed phenomenon will be minimized. 
6.2.1 Problem Formalization 
In order for the revised cell-dispensing domain to adhere to Equation (6-4), red and white 
blood cell concentrations must be uniform and equal to the reference-indicated value 
within the transition control volume for a duration that is at least equal to that of a sample 
analysis (~4 minutes).  The spatial composition of cells within the transition control 
volume is the result of transport taking place within the surrounding sedimenting body.  
The specifics of this transport will depend upon several uncontrollable factors such as 
sample rheology and sedimentation characteristics, as well as device-design parameters 
such as the rate of and direction from which bulk flow approaches the blood-holding-
volume outlet, and the cross-sectional dimensions of the volume itself.  In considering the 
optimization of the design parameters, there are two key conditions which should be met: 
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1. The initial distribution of cells within the blood-holding volume must be 
uniform and equal to the concentration within the un-processed blood 
specimen 
2. The bulk transport of cells within the blood-holding volume must be 
configured in such a way that does not compromise the initial conditions 
 
6.2.2 Initial Cell Distribution  
In 5.1, the scope of considerations regarding device-meaurement bias was extended to 
include elements of sample analysis which preceded the sedimentation process.  This 
discussion focused primarily on the implications of device loading within the subsequent 
cell-dispensing process.  While the mode of bias prescribed in that section pertained to 
the impact of sample inhomogeneity upon dispense-phase cell transport, the known 
causes of sample inhomogeneity discussed there are equally valid in the present context. 
Specifically leukocyte margination, the shear-induced inhomogeneity of WBCs within a 
whole blood flow, is a key consideration for the design of the blood-holding volume.   
 
While it would be convenient for the sake of optimization, leukocyte margination is not 
readily described by mathematical means.  In fact, the knowledge base regarding 
leukocyte margination is limited to experimental characterization of margination within 
microscale domains wherein passage size, hematocrit and wall shear rate have been 
shown to have substantial effects upon the cross-sectional distribution of white blood 
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cells [22] [30].  While these parametric analyses provide insight regarding margination in 
micro passages, there is limited information regarding WBC distributions in passages 
larger than 50[μm]. The lack of characterization in larger passages is likely due to the 
obscuration of in-flow WBCs by the optically-dense RBCs [31].   
 
The lack of a mathematical means for predicting margination poses a substantial hurdle 
for dispensing-domain optimization.  While an absence of theoretical utilities might 
otherwise be overcome through visual observation of WBC motion, existing literature 
refutes this as a valid means of development due to the inherent interference of red blood 
cells.  Because red blood cells are the driving force in margination [32], there is no way 
to remove the visual interference without disrupting the physical system.  As such, 
leukocyte margination, the key concern with regard to initial cell distribution within the 
blood-holding volume, is not a directly verifiable design consideration.  In light of this 
fact, an appropriate design direction must be selected to minimize margination effects.  In 
turn, the bias of WBC dispensing will serve to validate the efficacy of the resulting 
design in minimizing margination.  To that end, it may be possible to minimize the extent 
of WBC inhomogeneity through diligent selection of the blood-holding volume’s 
dimensions.   
 
The blood-holding volume has three primary dimensions.  The first is the volume’s 
length which must be suitably long as to afford an outlet location which is adjacent to the 
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cell suspension for the duration of an analysis.  In anticipating a maximum ESR value of 
150 [mm/hr], a four minute analyses would result in a 10[mm] advancement of the cell-
plasma interface.  To provide sufficient separation of the outlet from the top surface of 
the blood-holding volume, the volume length (𝑙𝑏ℎ𝑣) should be made ~20[mm] long with 
a centered or below-center outlet location.  The blood-holding volume has a rectangular 
cross-sectional profile; the height (ℎ𝑏ℎ𝑣) and width (𝑤𝑏ℎ𝑣) of which round out 
description of the blood-holding volume’s geometry. The height and width of the cross 
section can be held equal; the smallest dimension will be largely defining of shear effects 
so there is not much utility in varying the two independently.    
6.2.2.1 Margination Development as a Function of Channel-wise Position 
Leukocyte margination refers to the shear-induced redistribution of white blood cells 
within the profile of a whole blood flow.  For a given geometry, sample rheology, and 
bulk flow rate, white blood cells will be distributed at characteristic locations within the 
flow.  An example distribution, from [22], is shown in Figure 6-3 wherein white blood 
cells are shown to be substantially more concentrated near the channel edge and less 
concentrated near the channel center.   The illustrated cell distribution was observed at 
the outlet of a 3.6[mm] long, 69 [μm] diameter tube.  The extreme length of the tube 
relative to its diameter ensures development of the cell distribution.  This notion--that of 
a margination-development length—presents a route by which margination effects can be 
minimized. 
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Figure 6-3  From [22]:  Left panel: Photograph (multiple exposure) of the distal opening of a 69- μm 
tube with fluorescent leukocytes passing the focal plane of the objective.  Right panel: Division of the 
tube cross section into six concentric rings of 5.8- μm width. The black dots represent the position of 
WBCs passing the focal place of the microscope. 
While margination is an innate consequence of shearing whole blood, the extent of 
margination can be managed by configuring the flow domain such that the characteristic 
length over which margination develops is significantly greater than the pertinent length 
over which blood is sheared in practice.  In other words, the cross section of the blood-
holding volume can be designed such that shear through the blood-holding volume’s 
length produces an insignificant change in WBC distribution.  Intuitively, it can be 
assumed that the length required for margination to have a profound effect on white 
blood cell distribution (𝑙𝑚𝑎𝑟𝑔𝑖𝑛𝑎𝑡𝑖𝑜𝑛) will increase with the characteristic length scale of 
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the domain (𝑤𝑏ℎ𝑣).  Additionally, it is desired that the domain length (𝑙𝑏ℎ𝑣) be less than 
the characteristic length of margination as expressed in Equation (6-5). 
𝑙𝑏ℎ𝑣
𝑙𝑚𝑎𝑟𝑔𝑖𝑛𝑎𝑡𝑖𝑜𝑛
⁄ < 1  (6-5) 
If the characteristic margination length does in fact increase as the passage size increases, 
the ratio of domain length  (𝑙𝑏ℎ𝑣) to margination length (𝑙𝑚𝑎𝑟𝑔𝑖𝑛𝑎𝑡𝑖𝑜𝑛) can be minimized 
by expanding the blood-holding volume cross section.  While this assertion rests on a 
number of intuitive assumptions, the lack of theoretical and experimental means for 
verifying a given design results in the need for guess-and-check; the only way to verify 
that a particular domain prevents significant margination is infer the presence or absence 
of margination from adherence of observed cell transport rates to the prescribed process 
description.  
6.2.3 Bulk Cell Transport 
In addition to determining the extent of WBC margination, the blood-holding-volume 
cross section is a significant factor in the bulk transport taking place therein.  To explain, 
a diagram of transport near the blood-holding volume outlet is provided in Figure 6-4.  
There, the bulk volumetric flow rates into the outlet region is said to be equal to the 
volumetric flow rate through the outlet.  Additionally, the cumulative cell transport into 
the outlet-adjacent region of the volume is equal to the sum of the outlet transport rate 
and rate of change in the number of bounded particles.   
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Figure 6-4  Transport diagram for the central region of the blood-holding volume 
In practice, (?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑 =  ?̇?1  +  ?̇?2) while the ratio of (?̇?1) to (?̇?2) depends on the 
manner of pusher fluid delivery into blood-holding volume.  For each of the devices 
utilized henceforth, the relative buoyancy of the pusher fluid (DI water) requires that 
(?̇?2 = 0) so as to avoid dilution of the blood sample; fluid injected at the bottom of the 
blood-holding volume would float up and into the cell suspension.  As such, for the 
devices tested within this research: (?̇?1 =  ?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑).  The asymmetry of the bulk 
flow within the system is cause for concern.   
 
The desired operation of the revised dispensing geometry assumes that the sedimentation 
effect upon cell transport will be inversely proportional in the upper and lower portions of 
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the blood-holding volume; gravitationally-enhanced transport of red cells from the upper 
half of the volume (?̇?1) is balanced by the gravitationally-inhibited RBC transport 
coming from the lower half.  Thus, the absence of bulk flow in the lower portion of the 
blood-holding volume requires that the bulk flow in the upper portion of the domain not 
affect the sedimentation process.  The shear enhancement of sedimentation described in 
Section 5.2 is especially relevant with regard to this necessary condition.  Specifically, it 
is important that the blood-holding volume cross section and the bulk volumetric flow 
rate do not produce fluidic shear rates in the sedimentation-enhancing range.  
6.3 Experimental Testing of the Revised Dispensing Domain 
While the principles behind the optimized transport domain promise that it may be a 
sound method for reducing gravitational transport bias, experimental testing is the true 
measure of an analytical device.  As such, it is necessary to implement the optimized 
transport domain within a microdevice as a means for gauging the efficacy of the 
optimized cell-dispensing circuit.  In order to demonstrate the change in device 
performance brought about by the transport-domain optimization, a new microdevice 
design was tested using the same comparability-test format that had yielded observations 
of gravity-enhanced transport.  The following sections describe this new microdevice, its 
features, the measurement protocol that is executed within the device, and the 
experimental test procedure used to gauge the revised device’s performance. 
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6.3.1 Microdevice 
An overview of the optimized microdevice, containing the reconfigured cell-dispensing 
feature, is shown in Figure 6-5.  As with the prior microdevice, the revised device’s 
fluidic circuit takes a three-part format beginning with cell dispensing, dispensed cells 
then enter a cell-processing circuit, and the processed cells eventually enter a cell-
focusing feature where they are analyzed. While the cell-focusing portion of the revised 
device does not differ in format from the previous device, both the cell-dispensing and 
cell-processing features were modified.  As such, subsequent sections provide detailed 
information regarding the structure and functionality of these device features.     
 
Figure 6-5  Annotated layout of the optimized microfluidic device 
6.3.1.1 Cell Dispensing 
The revised microdevice makes use of an embodiment of the gravity-unbiased cell-
dispensing domain.  As described previously, this domain has undefined dimensional 
parameters and post-outlet geometry.  Intuitively, the sedimentation domain must have a 
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length which allows for an outlet position which falls between the phase interfaces of the 
sedimenting whole blood.  Because of this, the domain is 20 millimeters long; long 
enough that a sample with an ESR of 150 [mm/hr] will not result in the cell-plasma 
interface eclipsing a centrally-located outlet during a test that is four minutes in duration.   
 
The sedimenting domain’s cross section is most easily fabricated as a rectangular 
channel.  Additionally, as the smallest cross-sectional dimension is likely to instigate 
shear-dependent physics such as margination (shear-induced inhomogeneity of WBCs 
within the flow profile), and because minimization of specimen volume is always 
beneficial in point-of-care devices, it is sensible to utilize a unity aspect ratio in 
constructing the sedimenting domain.  Thus, the sedimenting domain within the 
optimized microdevice has a square cross-sectional profile.  The choice of the appropriate 
dimension for the domain cross section is a complex question.  On the one hand, a large 
cross section further minimizes the shear-induced transport effects (such as margination 
and sediment enhancement).  Oppositely, reduction of the cross-sectional area of the 
sedimenting domain will decrease the effect that sedimentation imbalance between the 
upper and lower domain halves would have upon the outlet-adjacent domain region.  
Here, the chief cause of sedimentation balance is itself a shear-induced sedimentation 
enhancement (overview provided in Section 5.2).  Because shear-enhanced sedimentation 
can be substantially minimized with an increase in cross-sectional area and subsequent 
reduction of shear, the desired cell-dispense accuracy was achieved through the selection 
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of a cross-sectional area which minimizes the WBC-biasing effects of leukocyte 
margination and ensures that the in-domain shear levels are such that ESR enhancement 
due to fluid shear is does not occur: the cross section of the cell-dispensing volume is a 
0.8x0.8 [mm] square. 
 
6.3.1.2 Cell Processing 
Within the scope of cell processing, there are a number of key functions which must be 
provided in order to convert whole blood into singular, analyzable cells.  Specifically, 
aggregates of cells within whole blood must be broken up so that the individual cells are 
exposed to cell-preparation reactants for a sufficient duration to bring the particular 
reaction to completion.  In a macro-scale system, these actions may be as simple as to 
inject a volume of blood into a large volume of processing reactant and vigorously 
stirring the mixture for an appropriate duration.  On the micro scale, mixing of 
particulates such as blood cells with liquid chemicals is complicated by the fact that 
momentum-dependent mixing is limited or altogether absent.  As a consequence, 
penetration of processing chemicals into the whole blood matrix is almost entirely 
dependent upon diffusion.  Therefore, a device is well served by a reduction in the path 
length of diffusion which must be penetrated as a precursory step to cell-chemical 
reaction.   
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Figure 6-6  Illustration of the initial portion of the optimized cell-processing circuit 
In the cell-processing circuit shown in Figure 6-6, whole blood combines with a 
processing reagent stream at a T-junction.  The reactant crossflow traps blood against the 
inside wall of the outlet channel where cells and cell aggregates are sheared.  The shear 
along this wall is configured to disaggregate whole blood, resulting in a downstream flow 
of individualized cells.  Downstream of the blood-reagent junction, there is a second T-
junction.  At this T-junction, the cell-reactant combined flow (an ordered side-by-side 
flow, not a mixture) meets with a second reactant flow.  As the cell-reagent flow exits the 
second T-junction, the disaggregated blood cells are entrained by the reagent flows.  In 
the revised device, the width of the cell-containing portion of the exiting flow, which can 
be described by a Hele-Shaw model, is configured to be near to or less than the size of a 
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blood cell.  As such, the time of diffusion within the revised device is negligible 
compared to the time of reaction. 
 
With the time of diffusion approaching zero, the residence time of cells within the 
processing reactant needs to be configured to match the cell-reactant reaction time, a 
reasonably constant factor.  An optimal residence time was determined to be (~10[s]) and 
was implemented by adjusting the volume of the lengthy channel downstream of the cell-
processing junction such that the quotient of that channel volume over the volumetric 
flow rate of the side-by-side-by-side flow was equal to the estimated  reaction time.   
6.3.2 Measurement Routine 
For the previous experiments, the overwhelming abundance of red blood cells within 
whole blood required that a supplementary fluid step be used to perform red blood cell 
quantitation.  For the current set of experiments, an upgraded electronics system enables 
the elimination of the supplementary fluidic step.  As such, both the RBC and WBC-
concentration measurement routines consist of the establishment of a steady transport 
state for which the cell transport rate at the point of detection are assumed to be 
consistent with Equation (1-1).  The fluidic pumping rates and process timing for testing 
of the revised microdevice are detailed in routine 6A, provided in Appendix B.  
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6.3.3 Experimental Procedure 
In order to gauge the efficacy of the gravitationally-unbiased transport domain, the 
revised microdevice design was tested using a comparison study similar to that used to 
analyze the predicate device in Chapter 3.  For this comparison study, 20 unique blood 
specimens were analyzed.  Each analysis yielded a value for both white and red blood 
cell concentration. Because the cell-dispensing process is time-invariant for the revised 
device, there is no need to exclude one or the other measurement based on the need for 
development of a steady sedimentation condition.  Therefore, each analysis provided a 
pertinent indication of both RBC and WBC measurement bias for the gravity-negating 
domain.  Each analysis was performed using a constant measurement routine: routine 6A.  
6.4 Results 
6.4.1 RBC Concentration Measurements 
The RBC concentration of each sample was measured using both the optimized 
microdevice and a reference instrument: an Abbott Cell Dyn 3200.  As in the previous 
comparability study, the reference instrument provided the standard against which the 
accuracy of revised device measurements can be gauged.  A datum for each measurement 
is provided in Figure 6-7 which illustrates the correlation between RBC measurements 
made on the microdevice and reference instrument.  Overall, the data demonstrates that 
the revised device produced a weaker correlation (R
2
 = 0.74 vs R
2
 = 0.85) but was closer 
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to unity with the reference instrument (slope = 0.90 vs slope = 0.65) than the initial 
microdevice. 
 
Figure 6-7  Scatterplot illustrating the correlation between microdevice and reference instrument 
measurements for RBC concentration 
6.4.2 WBC Concentration Measurements 
A correlation of the measurements generated by the microdevice and reference 
instrument is provided in Figure 6-8.  The plot of WBC measurements show a stronger 
correlation (R
2
 = 0.96 vs R
2
 = 0.91) and closer unity to the reference instrument (slope = 
0.96 vs slope = 0.62) than the initial microdevice. 
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Figure 6-8  Scatterplot illustrating the correlation between microdevice and reference measurements 
of WBC concentration 
6.5 Conclusions 
A primary purpose of optimizing the cell transport domain was to circumvent the RBC-
transport enhancement and WBC-transport inhibition which gravity had instigated in the 
initial microdevice.  To that end, the revised transport domain appears to have been 
somewhat effective. The extent of RBC and WBC bias in the low-RBC range, as plotted 
in Figure 6-9, appears to be less dramatic than was the case for measurements taken on 
the initial microdevice.   
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Figure 6-9  RBC and WBC biases for Concentration Measurements using the Optimized Microdevice 
Still, it seems that the rate of cell dispensing facilitated by the revised cell-dispensing 
domain does not fit description by Equation (1-1).  In fact, over the tested RBC range, 
RBC and WBC bias again show a general trend of inverse proportionality. While this 
trend is akin to that observed in bias plots of initial device measurements, the mechanism 
by which the trend in Figure 6-9 was found to develop is indirectly related to the 
principles of operation stated for the revised cell-dispensing domain.  An explanation of 
the biasing mechanism and testing of a new device based on the unforeseen facet of cell 
transport is provided in Chapter 7:. 
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Chapter 7: Directionality of Outlet Transport 
 
 
In Chapter 6:, principles were set forth which described the manner in which a 
gravitationally-unbiased, cell-dispensing domain would produce RBC and WBC 
concentration measurements which were more accurate than measurements generated by 
the gravitationally-biased transport system tested in Chapter 3:.  While measurements 
facilitated by the revised transport domain (that tested in Chapter 6) were reasonably 
more ‘true’ to measurements generated on a reference instrument, the change in 
performance relative to the initial device was insignificant.  For each of the previously-
tested devices, RBC and WBC measurement bias tended to be inversely proportional 
with device-generated RBC measurements exceeding reference values and WBC 
measurements coming short of reference values by a similar magnitude.   
 
For the initial microdevice, the inverse bias of cell-concentration measurements was 
linked to the whole blood sedimentation process by which red blood cell transport was 
enhanced by gravity and, conversely, white blood cells transport was inhibited.  
Naturally, this experience provided a natural path of inquiry for the mechanism by which 
inverse measurement bias was generated by the revised transport system.  However, the 
principles by which the revised cell-dispensing domain was derived were specifically 
aimed at negating gravitational effects.  By what means, then, would sedimentation factor 
into cell transport?  Although the foundation of domain operation set in Chapter 6: is 
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sound, the stated conditions omit a simple practical consideration: The formula for outlet 
cell transport prescribed in Equation (6-4), while valid within the sedimenting domain, is 
invalid in the horizontal, outlet-adjoining channel wherein sedimentation produces phase 
separation.  The phase separation in the outlet-adjoining channel violates the assumptions 
on which Equation (6-4) is founded.  Reverse flow across the outlet plane represents a 
deviation from the ideal conditions which can give rise to biased transport.  The 
following sections further this notion, describe the physical cause of reversed outlet flow 
within the prior microdevice, detail a simulation of the mechanics of said cause as well as 
a mitigating design change, and outline the experimental testing of a microdevice which 
makes use of the gravity-bias-negating domain and revised outlet-adjoining channel. 
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7.1 Outlet Flow Recirculation as Transport Bias 
To expand upon the prior notion—that reversed flow across the dispense-domain outlet 
results in an effective transport bias—consider the transport relationship for the example 
velocity profiles in Figure 7-1.  There, profile (a) represents an outlet velocity condition 
which includes a flow recirculation while profile (b) represents an outlet velocity 
condition that is free of recirculation.  Within the context of this discussion, the profiles 
represent hypothetical, outlet-normal velocity profiles at the blood-holding-volume 
outlet.   
 
Figure 7-1 Model velocity profiles for reversed (a) and forward (b) bulk transport 
Per the discussion of volumetric transport in Chapter 6:, the surface integral of each 
profile must be equal to the pusher fluid flow rate (?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑).  This implies that, for 
profile (a), the forward bulk transport must be equal to the pusher fluid flow rate plus the 
reversed volumetric flow rate: expressed in Equation (7-1).  
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?̇?𝑓𝑜𝑟𝑤𝑎𝑟𝑑,(𝑎) =  ?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑 + ?̇?𝑟𝑒𝑣𝑒𝑟𝑠𝑒,(𝑎)  (7-1) 
With that, the cell transport in the forward-moving portion of profile (a) can be described 
as in Equation (7-2) wherein the concentration of forward-moving cells is determined by 
the blood-holding volume and is therefore believed to be equal to a reference-indicated 
concentration. 
?̇?𝑓𝑜𝑟𝑤𝑎𝑟𝑑,(𝑎) =  𝑐𝑟𝑒𝑓 ∗  (?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑 +  ?̇?𝑟𝑒𝑣𝑒𝑟𝑠𝑒,(𝑎))  (7-2) 
 Cell transport within the reverse-flow portion of profile (a) complicated by the unknown 
cell distribution downstream of the blood-holding-volume outlet (recall the context of 
this discussion).  Here, it is sufficient to apply a transport-averaged (𝑐′ =  
?̇?
?̇?
), effective 
cell concentration that satisfies the identity given in Equation (7-3).  
?̇?𝑟𝑒𝑣𝑒𝑟𝑠𝑒,(𝑎) =  𝑐
′ ∗  ?̇?𝑟𝑒𝑣𝑒𝑟𝑠𝑒,(𝑎)  (7-3) 
Ultimately, the flow reversal will result in a net cell transport equivalent to that described 
in Equation (7-4). 
?̇?(𝑎) =  𝑐𝑟𝑒𝑓 ∗  (?̇?𝑝𝑢𝑠ℎ𝑒𝑟 𝑓𝑙𝑢𝑖𝑑 +  ?̇?𝑟𝑒𝑣𝑒𝑟𝑠𝑒,(𝑎))  −  𝑐
′ ∗  ?̇?𝑟𝑒𝑣𝑒𝑟𝑠𝑒,(𝑎) (7-4) 
As previously stated, Equation (7-4) confirms that for a reverse flow in which reversing 
cell concentrations do not match the reference-indicated concentration, the gravity-
negating transport domain will produce transport (and therefore concentration 
measurements) which deviate from expected.  The extent to which a given measurement 
will deviate from expected is dependent upon the concentration of a given cell type 
within the flow recirculation.   
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7.2  Density-Driven Outlet Flow Recirculation 
 
 
Figure 7-2  Illustration of phase separation in outlet-adjoining channel 
  
Figure 7-2 illustrates a three-region media separation within the outlet-adjoining channel 
with cell-free plasma along the upper channel surface, below which is a region of 
suspended cells and below which is a packed-cell region.  While the indicated phase 
boundaries are not physically accurate, they allow the physical concern with phase 
separation to be illustrated.  The bulk flow within the sedimenting domain and adjoining 
channel is extremely slow.  As such, the dynamics of cell transport within these volumes 
should be akin to the transport in a static situation.  If, for the sake of argument, the 
volume shown in Figure 7-2 were left to sit for an extended period under a zero-flow 
condition, the region of plasma which formed at the top surface of the horizontal channel 
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would be propelled backward into the suspension-filled sedimentation domain.  The 
jettison of plasma from the horizontal channel is due to the pressure difference brought 
about by phase separation.  To explain this, four points of pressure reference are provided 
in Figure 7-2.  Because the theorized system is at rest, 𝑃1 and 𝑃3 can be assumed equal 
since they are at equal height and the isobaric line connecting the two points falls within a 
constant phase.  𝑃2 relates to 𝑃1 through Equation (7-5) from hydrostatics: 𝑃2 is less than 
𝑃1by an amount equal to the specific weight of the cell suspension multiplied by the 
distance separating the two points.   
 
    𝑃2 =  𝑃1 −  𝛾𝑠𝑢𝑠𝑝𝑒𝑛𝑠𝑖𝑜𝑛 ∗ (𝑦2 −  𝑦1)   (7-5) 
 
 Likewise, 𝑃4 and 𝑃3are related by Equation (7-6) which is identical in form to Equation 
(7-5) but differs in that the specific weight reflects the plasma phase which separates the 
two points. 
    𝑃4 =  𝑃3 − 𝛾𝑝𝑙𝑎𝑠𝑚𝑎 ∗ (𝑦2 −  𝑦1)   (7-6) 
Because the specific weight of plasma is less than that of the cell suspension, 𝑃4 differs 
from 𝑃1 and 𝑃3 to lesser extent than does 𝑃2.  Since 𝑃4and 𝑃2are at equal height within the 
domain, the pressure difference between the two creates an unbalanced thermodynamic 
state which should bring about counter-gradient bulk motion and subsequent viscous 
stresses which will bring thermodynamic balance to the system.  Although this 
description can be cleanly applied to a static system, bulk flow introduces a great deal of 
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complexity with regard to the balance between the shearing effect of bulk motion and the 
phase-separation-based pressure differential.  Under rapid flow conditions, it would be 
expected that viscous effects would drag the plasma phase along the channel regardless 
of the minute amount to which it was inclined to flow in the channel-reverse direction.  
Unfortunately, the drastically slow flow rate utilized in the cell-dispensing process does 
not allow for this physical effect to be ignored.  Due to the complexity of the physical 
system, numerical simulation is an appropriate means for determining the extent to which 
post-outlet sedimentation will affect outlet transport directionality.  The following section 
details a numerical scheme by which the dynamics within the cell-dispensing domain can 
be described and provides evidence that the previous microdevice was prone to density-
driven recirculation. 
 
7.3 Numerical Simulation of Outlet-adjacent Transport 
In order to analyze the outlet-adjacent domain, a Mixture Model of multiphase flow was 
employed.  The Mixture Model is preferred here because the mixture model description 
contains only one momentum-conservation equation [33].  Thus, there is no need to 
separate viscous stresses between individual phases.  As such, the rheological 
information provided by the literature can be easily implemented within the model.  
Similarly, the Mixture Model makes use of an interphase-velocity equation which enables 
direct control over localized sedimentation rates based on established ESR factors such as 
hematocrit.  The conservation equations within the model ensure that the effects of this 
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interphase motion are reflected in the mechanics of the transport domain.  This is 
precisely what is desired of the present problem; to determine the effects of a known 
sedimentation rate upon the transport of whole blood across the sedimenting domain 
outlet.  
 
The output of the simulation process should be twofold.  The first objective is to establish 
the existence of a density-based flow reversal within the previously-tested cell-dispensing 
domain.  Second, the insight provided by analysis of the previous design should inform 
domain optimization.  The latter of these interests is progressive and will require 
synthesis of new domain architectures which can be analyzed by the numerical model 
and, subsequently, tested experimentally.   
 
7.3.1 Mixture Model  
The Mixture Model consists of three primary equations.  The first, shown in Equation (7-
7) is the continuity equation which expresses mixture-mass conservation wherein the 
mixture is a combination of ‘n’ number of phases.  The second equation is the mixture 
momentum equation.  This momentum equation accounts for all energy transfer within 
the model and, as such deals with tensor quantities of the ‘mixture’ rather than its 
constituent elements.  The momentum equation is stated here as in Equation (7-8).  
Finally, the mixture model incorporates ‘n’ number of phase-continuity equations: 
Equation (7-9).  
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𝜕𝜌𝑚
𝜕𝑡
=  ∇ ∙ (𝜌𝑚𝑢𝑚) = 0   (7-7) 
 
    
𝜕
𝜕𝑡
𝜌𝑚𝑢𝑚 + ∇ ∙ (𝜌𝑚𝑢𝑚𝑢𝑚) =  −∇𝑝𝑚 −  ∇ ∙ [𝜌𝑚𝑐𝑝(1 − 𝑐𝑝)𝑢𝐶𝑝0𝑢𝐶𝑝0] +  ∇ ∙ 𝜏𝑚 +  𝜌𝑚𝑔    (7-8) 
 
    
𝜕𝛼𝑝
𝜕𝑡
+ ∇ ∙ (𝛼𝑝𝑢𝑚 − 𝐷𝑀𝑝∇𝛼𝑝) =  −∇ ∙ [𝛼𝑝(1 − 𝑐𝑝)𝑢𝑐𝑝0]   (7-9) 
  
Implementation of the Mixture Model requires a number of parameters such as phase 
densities (here, red blood cells and plasma) which are readily obtained from physiology 
literature. In addition, models are needed for the viscous effects (𝜏𝑚) and interphase 
velocity(𝑢𝑐𝑝0).  
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7.3.2 Relative Velocity 
 
Figure 7-3  Chart of ESR-HCT relationship used within the numerical simulation 
The primary form of interphase motion within the target system is gravity-driven 
sedimentation.  Although sedimentation is the product of a phase-density imbalance with 
the rate being governed by the effective porosity of the suspended phase, the modeling of 
relative velocity does not need to incorporate the mechanics of this process.  In fact, for 
the system of whole blood described here, it is convenient to apply a description of 
relative velocity which is a function of its primary intensive determinate: hematocrit 
(HCT).  Borrowing from the data generated in a survey study by Lawrence and Fabry 
[21], a general function describing ESR as a function of hematocrit was derived.  The 
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data (which were manually selected to coincide with the data bounds from [21]) driving 
this function, as well as the function itself, are shown in Figure 7-3.  
 
Within the model employed here, the settling velocity of the dispersed (red blood cell) 
phase is calculated for individual (numerical) cells based on the HCT value of said cell.  
This scheme effectively captures the appropriate localized sedimentation without the 
need for computing phase interaction (which is primarily dictated by HCT).  
7.3.3 Simulation Strategy 
For each of the simulations described here, results were generated by a transient 
simulation of the cell transport taking place within the fluid domain.  Initial conditions 
for pressure, velocity, and phase volume fractions were generated by a preceding steady-
state simulation of each domain.  In each of these steady-state simulations, the domain 
and boundary conditions were the same as in the corresponding transient simulation. 
However, the interphase velocity was omitted from each of the steady solutions.  As a 
result, the initial solutions provided by the steady-state simulations provided an 
approximate velocity and pressure field solution for the subsequent transient analysis; the 
initial phase-volume-fraction field was also specified by the inlet phase volume fraction 
used in the steady analyses.  The conditions for each transient analysis, then, differed 
from the preceding steady-state simulation only through the incorporation of the 
previously prescribed relative-velocity model.   
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7.4 Baseline Domain Simulation 
 
Figure 7-4 Diagram of the baseline simulation domain 
The baseline simulation domain, shown in Figure 7-4, consists of a clipped segment of 
the blood-holding volume which includes the outlet and outlet-adjoining channel.  
Conveniently, the region of interest allows for further reduction in domain volume by 
way of planar symmetry: The symmetry plane is indicated in Figure 7-4.   
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7.4.1 Parameters 
Table 3 Baseline domain simulation: material and boundary parameters 
Parameter Value Units 
Inlet Volumetric Flow Rate 0.1 [μL/min] 
Plasma Density 1025 [kg/m3] 
Red Blood Cell Density 1125 [kg/m3] 
Hematocrit (HCT) 0.3 - 
Plasma Viscosity 0.0015 [Pa*s] 
7.4.2 Results 
 
Figure 7-5 Plot of cell-volume fraction within the outlet region of the baseline simulation domain 
Figure 7-5 provides a plot of the cell-volume fraction along the symmetry plane of the 
transport domain for time point (t=10[s]).  As indicated in the figure, a pocket of plasma 
in the upper portion of the outlet-adjoining channel has spurred reverse flow across the 
  93 
outlet. More surprising than the recirculation is the size of the plasma region itself.  It 
appears that plasma buoyancy is not effectively countered by viscous effects acting to 
pull the plasma along with the rest of the bulk flow.   
 
This presents an interesting thought: the buoyant stresses propelling plasma toward the 
upper bound of this channel are, here, countered by viscous stresses that are 
predominately the product of plasma viscosity.  Plasma viscosity is orders less than the 
viscosity of the plasma-cell mixture.  Therefore, if the physical situation were reversed 
plasma would be buoyantly driven up and out of an upturned outlet-adjoining channel.  
Meanwhile, packed-cells would form a region similar that of the plasma within the 
current system.  Unlike the plasma, though, packed-cells would have an even higher 
effective viscosity than the root cells suspension.  As such the packed cells, though also 
compelled toward the main portion of the domain by a density differential, would be 
more-strongly bound to the bulk flow by viscous stress.  Consequently, a 180° turn of the 
outlet-adjoining channel would result in a trade-off: plasma, the likeliest phase to reverse 
flow, would be naturally compelled out of the domain while packed cells would be swept 
along with the bulk flow due to relatively large viscous stresses afforded by cell-
containing regions of transport.    
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7.5 Revised Domain Simulation 
 
Figure 7-6 Diagram of the revised simulation domain 
The revised simulation domain is dimensionally identical to that of the baseline 
simulation.  Changes to the domain are indicated in Figure 7-6.  There, the outlet, 
symmetry plane, and domain structure remain the same while the inlet has moved from 
the upper ‘capping’ surface to the lower ‘capping’ surface and the gravity vector has 
rotated 180° so as to reflect a rotation of the outlet-adjoining channel.   
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7.5.1 Parameters 
Table 4 Revised domain simulation:  material and boundary parameters 
Parameter Value Units 
Inlet Volumetric Flow Rate 0.1 [μL/min] 
Plasma Density 1025 [kg/m3] 
Red Blood Cell Density 1125 [kg/m3] 
Hematocrit (HCT) 0.3 - 
Plasma Viscosity 0.0015 [Pa*s] 
 
7.5.2 Results 
 
Figure 7-7 Plot of cell-volume fraction within the outlet region of the revised simulation domain 
Figure 7-7 provides a plot of cell-volume fraction along the symmetry plane of the 
revised transport domain for time point (t=10[s]). Whereas in the baseline domain plasma 
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had gathered in the upper portion of the outlet-adjoining channel, the effective rotation of 
the domain has, as intended, reduced the extent of plasma-separation in the post-outlet 
region.  Additionally, the packed-cell region at the bottom of the outlet-adjoining channel 
does not appear to result in a reversed flow into the blood-holding domain.  Both of these 
findings are consistent with expectations and suggest that revision of the prior 
microdevice may be as simple as to rotate the outlet-adjoining channel 180°. 
7.6 Experimental Testing of Revised Outlet-adjoining Channel 
Numerical simulation of the cell-dispensing domain, having a revised outlet-adjoining 
channel, suggests that a simple reconfiguration of post-outlet geometry will eliminate the 
flow recirculation which had likely ailed the prior device (the device tested in Chapter 6).  
This design change was incorporated into a microdevice which utilized all of the key 
technical elements from the Chapter 6 microdevice; the two are functionally identical 
except for the outlet-adjoining channel.   
7.6.1 Microdevice 
The layout of the microdevice having a revised outlet-adjoining channel is shown in 
Figure 7-8.  As noted in the previous section, the functional elements of the new device 
are nearly identical to the device tested in Chapter 6.  The primary structural difference 
and only functional change between the two devices is a 180° rotation made to the outlet-
adjoining channel.   
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Figure 7-8  Annotated layout of the optimized microdevice with revised outlet-adjoining channel 
7.6.1.1 Revised Outlet-Adjoining Channel 
Figure 7-9 illustrates the transition of whole blood from the blood-holding volume to the 
cell-processing circuit within the new microdevice design.  The revised outlet-adjoining 
channel is highlighted there.  Whereas the flow within the outlet-adjoining channel in the 
Chapter 6 device had facilitated a downward flow, the revised channel conveys an 
upward flow.  The direction of this flow is in keeping with the numerical simulation s 
from the prior section which had shown that an upward-moving outlet flow would relieve 
the build-up of plasma that had yielded an outlet-flow reversal in the prior microdevice.  
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Figure 7-9  Detail view of whole blood transitioning from the blood-holding volume to the cell-
processing circuit 
7.6.2 Measurement Routine 
The measurement routine used in this final set of testing was identical to the test routine 
utilized in Chapter 6:.  The fluidic pumping rates and process timing for testing of the 
revised microdevice are detailed in routine 7A, provided in Appendix B. 
7.6.3 Experimental Procedure 
As with each of the prior two microdevices, experimental testing of the microdevice 
having both a gravity-negating dispense domain and revised outlet-adjoining channel 
consisted of RBC and WBC concentration measurement for a set of blood specimens 
having varied composition. In all, 12 unique samples were analyzed.  For each sample 
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analysis, both an RBC and WBC concentration was generated.  Each analysis was 
performed using the same measurement routine: routine 7A. 
7.7 Results 
7.7.1 RBC Concentration Measurements 
 
Figure 7-10  Scatterplot illustrating the correlation between microdevice and reference instrument 
measurements for RBC concentration 
The RBC concentration of each sample was measured using both the optimized 
microdevice and reference instrument: an Abbott Cell Dyn 3200.  A datum for each 
measurement is provided in Figure 7-10 which illustrates the correlation between RBC 
measurements made on the optimized microdevice and reference instruments.  The data 
shows that the optimized device produced a stronger correlation (R
2
 = 0.91 vs R
2
 = 0.85) 
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and had better linearity relative to the reference instrument (slope = 1.05 vs slope = 0.65) 
than the initial microdevice.   
7.7.2 WBC Concentration Measurements 
 
Figure 7-11  Scatterplot illustrating the correlation between microdevice and reference 
measurements of WBC concentration 
The WBC concentration of each sample was measured using both the microdevice and 
reference instrument.  A correlation of the measurements performed on each technology 
is provided in Figure 7-11.  Again, the plot of WBC measurements show a stronger 
correlation (R
2
 = 0.98 vs R
2
 = 0.907) and closer unity to the reference instrument (slope = 
0.99 vs slope = 0.62) than the initial microdevice. 
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7.8 Conclusions 
The microdevice tested within this chapter differed minimally from the device tested in 
Chapter 6.  In fact, the only functional change was to rotate the outlet-adjoining channel 
180°.  Numerical simulation of the revised cell-dispensing domain showed that the 
potential for an outlet-flow recirculation was minimized by this change.  The 
experimental data confirms this notion.  Whereas the previous version of the 
gravitationally-unbiased domain produced a general trend of inverse bias between RBC 
and WBC measurements, the revised device bias, shown in Figure 7-12, is distributed 
consistently about the x-axis as one would expect for a properly-functioning system.  
 
Figure 7-12  RBC and WBC biases for Concentration Measurements using the Optimized 
Microdevice 
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The relatively consistent bias across the biological range of RBC concentration shows 
stark contrast to the bias plot of measurements generated by both the initial device and 
the first iteration of the gravitationally-unbiased device.  In each of the prior devices, 
RBC and WBC bias had bifurcated in the mid-to-low RBC range (see Figure 4-1) where 
the erythrocyte sedimentation rate becomes elevated.  Independence of the cell-
dispensing process from elevated ESR in the low-RBC-concentration range suggests that 
the optimized transport domain was extremely effective at negating the gravitational 
transport bias illustrated by the initial device as well as the reversed-outlet-flow bias 
within the prior device design. 
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Chapter 8: Summary of Results and Conclusions 
 
This research was motivated by the desire to create a microfluidic technology which 
accurately quantifies the concentration of red and white blood cells within a whole blood 
specimen.  Experiments performed utilizing an initial design suggested that whole blood 
transport would have a profound impact upon the efficacy of such a technology.  
Consequently, a great portion of this research emphasized characterization and analysis 
of cell transport within whole blood microflows.   
 
Data interpretation and transport analysis drew heavily from the field of hemorheology, 
especially with regard to identification of the primary mechanics of cell transport within 
whole blood microflows.  The established rheological mechanics were linked to in-device 
transport through a kinematic identity: derived in Appendix A.  Post-hoc analysis of 
microdevice, cell-concentration measurements strongly suggested erythrocyte 
sedimentation as the primary mechanism affecting cell transport within the initial 
microdevice design.  Additionally, a theory was generated in which cell margination 
(shear-induced inhomogeneity) was expected to affect cell transport in situations where 
the magnitude of bulk blood flow rate shifts in such a way that the normalized flow-
domain velocity field changes due to the non-Newtonian properties of whole blood.  
From a practical standpoint, this conjecture raises concern for the potential impact of the 
manual introduction of blood specimens into a device wherein the rate of sample 
introduction is significantly more rapid than in-device operation.  Specifically, a device 
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which does not maintain a homogeneous distribution of cells should yield a cell transport 
rate which is a complex function of the cross-sectional cell distribution and flow-rate-
specific velocity profile. Because the normalized velocity profiles will differ between the 
‘device-loading’ and ‘operating’ conditions, a homogeneous cell distribution is needed to 
ensure that the cell-transport rate scales proportionately to the bulk flow rate. 
 
Ultimately, the learnings generated by analysis of the initial design informed a new, 
optimized, microdevice design which would support a cell-dispensing operation which 
was in close agreement to Equation (1-1).  In the initial microdevice, an increase in 
channel cross section would exaggerate the effects of sedimentation.  Because of this 
conflict, the cell transport domain had to be restructured in such a way that allowed 
simultaneous minimization of shear-induced cell inhomogeneity and minimization of 
sedimentation-based transport enhancement.   
 
The optimized transport domain made use of the inherent ‘stability’ of the spatial 
distribution of cells in a sedimenting body of whole blood.  By situating the outlet of the 
cell-dispensing transport domain at a location which, during the duration of a sample 
analysis, would be adjacent to the ‘suspension’ phase of the sedimenting whole blood, the 
effective concentration of dispensed cells would be constant.  Moreover, said outlet was 
designed such that the outlet ‘plane’, separating the sedimenting domain from the 
device’s microchannel segments, had a normal vector which was perpendicular to 
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gravity.  As such, the gravity-parallel velocity imposed on cells by the sedimentation 
process does not affect the transport rate across the outlet.  Conveniently, the gravity-
negating action of the optimized cell-dispensing domain did not fundamentally rely on a 
minimization of the flow-domain cross section, thereby allowing the cross section of the 
sedimenting domain to be increased as necessary to avoid spatial inhomogeneity and 
shear enhancement of sedimentation.    
 
On an initial pass, the re-designed transport domain had not produced significant gains in 
measurement accuracy.  It was found, through numerical simulation, that the first version 
of the revised transport domain had likely been affected by and issue related to flow 
recirculation within the dispense circuit.  Simulation also informed a revision to the 
circuit which promised to eliminate this recirculation.  This revision was incorporated 
within a new, optimized cell-dispensing domain.   The optimized cell-dispensing domain 
was tested in a microdevice in a manner comparable to the test procedure used to 
characterize transport in the initial device.  The linearity (compared to a reference 
instrument) of device-generated RBC and WBC concentration measurements suggest that 
the optimized transport domain was an effective solution for negating the gravitational 
effects suffered by the initial device.       
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8.1 Characterization of Transport in Whole Blood Microflows 
At the outset of this research, it was clear from the published literature that whole blood 
was an extremely well-characterized substance.  However, there was a noticeable lack of 
publications relating the general ensemble of knowledge to cell transport in micro-scale, 
in-vitro blood flows.  It seems likely that this paucity is due to the fragmented nature of 
the microfluidics field: technological challenges are largely application-specific.  While 
whole-blood sedimentation has been a chief concern in devices covered here, its 
significance was brought about by the general approach adopted within the researched 
microdevices: displace a near-micro volume of whole blood, in an undiluted state, at a 
rate which is, practically speaking, as close to a no-flow condition as one can imagine.  
This is perhaps a rate-controlling aspect of the development of point-of-care diagnostics 
in general; each new application requires developers to overcome a truly unique set of 
technical challenges. 
 
For the cell-counting application developed here, a chief concern was to control the rate 
of in-device cell transport through external control of the bulk volumetric flow rate of 
whole blood.  While the technical solution produced by transport characterization was 
shown to be quite effective in controlling cell transport rates, the breadth of general fluids 
knowledge generated was limited by means of characterization and the depth of 
understanding provided by the primary reference field: hemorheology.  Whole blood 
sedimentation, for instance, is a well-understood and easily-described process.  
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Subsequently, conclusions surrounding the effect of sedimentation upon RBC transport 
are concise and well-justified.  Although the leukocyte anti-sedimentation process was 
derived from the RBC sedimentation process, descriptions of the WBC transport rate did 
not adhere as cleanly to experimental data generated by the initial device.  There are 
many feasible explanations as to why WBC-transport defied logical description. 
 
One of the biggest frustrations with regard to characterization of WBC transport was the 
lack of mathematical descriptions of leukocyte margination.  Here, the likeliest secondary 
mode of transport bias (for WBCs) was not a mathematically-describable effect.  In 
general, a lapse in theoretical tools can be supplemented with experimental 
characterization.  While the studied microdevices provided quantitative feedback 
regarding cell transport rates, the cell kinematics which produced said transport rates 
would require direct observation of cell motion.  To that end, a fluorescence imaging 
apparatus was attempted which would enable in-situ observation of WBC transport 
within whole blood.  Due to the dense optical nature of red blood cells, white blood cells 
were found to be visible only near the surface of the flow domain; obscuring the pertinent 
region of flow.   
 
With roadblocks on both the theoretical and experimental paths toward a technical 
solution, the transition from the initial microdevice to the optimized microdevice 
depended strongly on intuition.  While a thorough developmental approach would 
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involve direct validation of the margination-negating effects of the optimized device, the 
WBC-transport rates indicated by concentration measurements have to supplement direct 
kinematic observation.  Thus, while the optimized device appears to support well-
controlled WBC transport, the ‘device loading’ effects described in Chapter 5 remain 
very much a hypothesis rather than a proven mechanism of transport.    
 
From the perspective of an overview, this research was very successful in demonstrating 
the use of Equation (A-5) in analysis and description of in-device cell transport rates.  
This equation and its derivatives were developed specifically for this project as a means 
for relating cell kinematics, which are the focus of most established literature, to the cell-
transport rates which were of chief concern here.  This description enabled 
characterization of the initial device, formalization of the device-loading hypothesis, and 
explanation of the physical means by which the transition control volume produces 
controlled cell transport in the optimized device.  Development and demonstration of this 
identity is, by a good measure, the most broadly-applicable product of this research.  
8.2 Advancement of Point-of-Care, Cell-counting Technology 
The realization of the initial microdevice to the optimized microdevice is the primary 
technological achievement of this research.  As stated previously, the merits of the 
gravity-negating effects of the optimized device are predicated on the shortcomings of the 
initial device: a relatively artificial product of the cell-dispensing approach to cell 
enumeration.  While the optimized transport domain is an application-specific 
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breakthrough, it is the application(s) which it promises to enable that is of interest.  
Because the value of point-of-care diagnostics is partly predicated on the expediency of 
results, it is important that a complete menu of diagnostic tests be available in a point-of-
care format.  To fill this menu is duty of application developers and is the path by which 
the optimized transport domain can contribute to the field of point-of-care diagnostics.   
 
It would be too bold to state that any characterization provided within this report was an 
indication of the viability of the optimized microdevice for use in medical diagnostic 
settings.  Aside from the extensive performance and reliability testing needed to make 
such a conclusion, development of a robust technology requires assurance of economical 
and usability traits which extend well beyond the scope of the present research. Thus, any 
technical solution which empowers a POC device should be judged solely on its ability to 
perform its intended function.  The optimized transport domain is intended to facilitate 
the cell-dispensing procedure as a means to quantify red and white blood cell 
concentration in whole blood specimens.  With regard to the latter, measurements 
generated by the optimized device suggest that the optimized transport domain is 
effective at facilitating in-device quantitation of cell concentration.  Thus, the 
technological objective of this research, to advance cell-counting POC technology, was 
achieved.              
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Appendix A: Derivation of Kinematic Description of 
Cell Transport in a Straight Channel Segment of 
Uniform Cross Section 
 
Describe the particle transport rate within a stream-wise element. Then, expand the 
description to apply to a closed channel particulate flow. 
?̇?𝑐.𝑣. =  
𝑁𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑎𝑡 𝑜𝑢𝑡𝑙𝑒𝑡
∆𝑡𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑡𝑖𝑜𝑛
 
(A-1) 
For an infinitesimal volume, the channel-wise velocity of bounded particles is uniform 
such that: 
𝑑?̇?  =   [𝑐𝑐𝑒𝑙𝑙 ∗ 𝑑𝐴 ∗ 𝑑𝑠] ∗  [
𝑣𝑠 ∗  𝑑𝐴
𝑑𝑠 ∗ 𝑑𝐴
] 
(A-2) 
Here, the first set of bracketed terms gives the quantity of cells bounded by the control 
volume and the second set of bracketed terms gives the ratio of channel-wise volumetric 
flow rate to the volume of the element.  This equation can be simplified through 
cancellation of terms to give Equation (A-3). 
𝑑?̇?  =   𝑐𝑐𝑒𝑙𝑙 ∗  𝑣𝑠 ∗ 𝑑𝐴 (A-3) 
The surface integral of Equation (A-3), across the channel cross section, can be expressed 
by Equation (A-4) which states that the net transport within the channel is the sum of the 
individual elements spanning the channel cross section.   
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?̇?𝑐ℎ𝑎𝑛𝑛𝑒𝑙 =  ∑ 𝑐𝑖 ∗  𝑣𝑠 ∗ 𝑑𝐴 =  ∑
𝑑𝑁
𝑑𝑠
 𝑣𝑠  
(A-4) 
Equation (A-4) can be re-written in a manner which reflects a constant channel-
wise length for the elements over which the summation is take which yields 
Equation (A-5).  Equation (A-5) represents the channel transport rate as the 
summation of channel-wise cell velocities for all cells within the cross-section-
spanning elements. 
 
?̇?𝑐ℎ𝑎𝑛𝑛𝑒𝑙 =  
∑ 𝑣𝑠,𝑖
𝑑𝑠
 
(A-5) 
The final step in deriving the desired description is to expand the observed 
region along the stream-wise direction so as to provide a volume-averaged 
transport rate, given in Equation (A-6).  
 
?̇?𝑐ℎ𝑎𝑛𝑛𝑒𝑙 =  
∑ 𝑣𝑠,𝑖
𝑁
𝑖=1
∆𝑠
 
(A-6) 
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Appendix B: Measurement Routine Tables 
Routine 3A   
Step 1 2 RBC 4 WBC 
Duration [s] 130 7 30 90 30 
Pusher Fluid Flow Rate [μL/min] 1 1 
M
ea
su
re
m
en
t 0.4 
M
ea
su
re
m
en
t 
 Sphere Flow Rate [μL/min] 200 0 0 
Lyse Fluid Flow Rate [μL/min] 0 0 27 
Sheath Fluid Flow Rate [μL/min] 0 400 700 
 
Routine 3B   
Step 1 WBC 3 4 RBC 
Duration [s] 135 30 90 7 30 
Pusher Fluid Flow Rate [μL/min] 0.4 
M
ea
su
re
m
en
t 1 1 
M
ea
su
re
m
en
t 
 Sphere Flow Rate [μL/min] 0 200 0 
Lyse Fluid Flow Rate [μL/min] 27 0 0 
Sheath Fluid Flow Rate [μL/min] 700 0 400 
 
Routine 6A   
Step 1 RBC 3 WBC 
Duration [s] 90 30 90 30 
Pusher Fluid Flow Rate [μL/min] 0.2 
M
ea
su
re
m
en
t 0.4 
M
ea
su
re
m
en
t 
 Sphere Flow Rate [μL/min] 50 0 
Lyse Fluid Flow Rate [μL/min] 0 20 
Sheath Fluid Flow Rate [μL/min] 2000 1000 
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Routine 7A   
Step 1 RBC 3 WBC 
Duration [s] 90 30 90 30 
Pusher Fluid Flow Rate [μL/min] 0.2 
M
ea
su
re
m
en
t 0.4 
M
ea
su
re
m
en
t 
 Sphere Flow Rate [μL/min] 50 0 
Lyse Fluid Flow Rate [μL/min] 0 20 
Sheath Fluid Flow Rate [μL/min] 2000 1000 
 
 
